| placebo |
placebo |
267 |
2014 |
| Other |
standard care |
52 |
2014 |
| Drug |
nesiritide |
17 |
2010 |
| Drug |
spironolactone |
17 |
2010 |
| Drug |
carvedilol |
16 |
2010 |
| Drug |
tolvaptan |
16 |
2016 |
| Drug |
valsartan |
16 |
2013 |
| Drug |
furosemide |
15 |
2009 |
| Drug |
levosimendan |
15 |
2012 |
| Drug |
enalapril |
14 |
2017 |
| Behavioral |
exercise |
14 |
2010 |
| Drug |
ivabradine |
14 |
2017 |
| Drug |
lcz696 |
14 |
2013 |
| Other |
control |
13 |
2016 |
| Device |
cardiac resynchronization therapy |
12 |
2018 |
| Drug |
sildenafil |
11 |
2010 |
| Other |
exercise training |
10 |
2016 |
| Drug |
empagliflozin |
9 |
2018 |
| Drug |
sacubitril |
9 |
2018 |
| Drug |
saline |
9 |
2016 |
| Drug |
dapagliflozin |
8 |
2016 |
| Drug |
allopurinol |
7 |
2014 |
| Drug |
atorvastatin |
7 |
2017 |
| Drug |
eplerenone |
7 |
2013 |
| Drug |
ferric carboxymaltose |
7 |
2013 |
| Device |
icd |
7 |
2010 |
| Drug |
metformin |
7 |
2010 |
| Other |
telemonitoring |
7 |
2018 |
| Drug |
anakinra |
6 |
2010 |
| Other |
attention control |
6 |
2010 |
| Device |
crt-d |
6 |
2014 |
| Behavioral |
education |
6 |
2017 |
| Drug |
vitamin d |
6 |
2013 |
| Drug |
aliskiren |
5 |
2009 |
| Drug |
bisoprolol |
5 |
2018 |
| Drug |
bms-986231 |
5 |
2016 |
| Drug |
candesartan |
5 |
2008 |
| Procedure |
cardiac rehabilitation |
5 |
2012 |
| Device |
crt |
5 |
2009 |
| Drug |
darbepoetin alfa |
5 |
2006 |
| Drug |
omecamtiv mecarbil |
5 |
2016 |
| Drug |
rosuvastatin |
5 |
2017 |
| Behavioral |
telehealth |
5 |
2017 |
| Procedure |
ultrafiltration |
5 |
2010 |
| Drug |
acetazolamide |
4 |
2011 |
| Drug |
bia 5-453 |
4 |
2017 |
| Other |
blood sample |
4 |
2012 |
| Drug |
cd-np |
4 |
2009 |
| Device |
cpap |
4 |
2015 |
| Drug |
digoxin |
4 |
2015 |
| Drug |
dobutamine |
4 |
2011 |
| Other |
echocardiography |
4 |
2019 |
| Drug |
empagliflozin 10 mg |
4 |
2017 |
| Behavioral |
health education |
4 |
2012 |
| Drug |
lcz696 (sacubitril |
4 |
2016 |
| Drug |
lcz696 (sacubitril/valsartan) |
4 |
2016 |
| Drug |
loop diuretics |
4 |
2019 |
| Device |
optimal medical therapy |
4 |
2014 |
| Device |
pacing lead |
4 |
2009 |
| Drug |
prednisone |
4 |
2014 |
| Drug |
rolofylline |
4 |
2008 |
| Drug |
sacubitril/valsartan |
4 |
2018 |
| Drug |
thiamine |
4 |
2010 |
| Drug |
valsartan) |
4 |
2016 |
| Drug |
ace inhibitor |
3 |
2006 |
| Procedure |
acupuncture |
3 |
2020 |
| Other |
aerobic |
3 |
2013 |
| Other |
aerobic training |
3 |
2016 |
| Drug |
amiodarone |
3 |
2008 |
| Other |
blood draw |
3 |
2011 |
| Drug |
ca125 guided strategy |
3 |
2015 |
| Drug |
cenderitide |
3 |
2011 |
| placebo |
comparator: placebo (unspecified) |
3 |
2006 |
| Drug |
diuretics |
3 |
2010 |
| placebo |
enalapril matching placebo |
3 |
2015 |
| Behavioral |
high-intensity imt |
3 |
2012 |
| Behavioral |
high-intensity interval training |
3 |
2016 |
| Other |
inspiratory muscle training |
3 |
2012 |
| Biological |
ixmyelocel-t |
3 |
2009 |
| Other |
life completion |
3 |
2010 |
| Drug |
liothyronine |
3 |
2011 |
| Drug |
liraglutide |
3 |
2011 |
| Other |
lung ultrasound |
3 |
2016 |
| Drug |
lysine chloride |
3 |
2018 |
| Drug |
nebivolol |
3 |
2014 |
| Dietary Supplement |
nitrate-rich beetroot juice |
3 |
2018 |
| Drug |
nitroglycerin |
3 |
2013 |
| Drug |
opc-41061(tolvaptan) |
3 |
2007 |
| Drug |
oxygen |
3 |
2019 |
| Drug |
patiromer |
3 |
2010 |
| Behavioral |
physical activity |
3 |
2017 |
| placebo |
placebo of enalapril |
3 |
2016 |
| placebo |
placebo of lcz696 |
3 |
2016 |
| Other |
positron emission tomography |
3 |
2015 |
| Drug |
ranolazine |
3 |
2011 |
| Other |
resistance training |
3 |
2018 |
| Drug |
rlx030 |
3 |
2013 |
| Other |
sham |
3 |
2012 |
| Drug |
sitagliptin |
3 |
2016 |
| Drug |
123i-mibg (meta-iodobenzylguanidine) |
2 |
2005 |
| Device |
a |
2 |
2007 |
| Device |
adaptive servo-ventilation |
2 |
2016 |
| Device |
adaptive servo ventilation |
2 |
2010 |
| Other |
advanced imaging |
2 |
2011 |
| Behavioral |
aerobic endurance exercise training (ergometer) |
2 |
2005 |
| Drug |
alt-711 |
2 |
2007 |
| Drug |
amlodipine |
2 |
2011 |
| Drug |
angiotensin ii type 1 receptor antagonists |
2 |
1999 |
| Drug |
aspirin |
2 |
2012 |
| Drug |
azd9977 |
2 |
2018 |
| Device |
b |
2 |
2007 |
| Device |
barostim neo system |
2 |
2011 |
| Device |
barostim neoâ® system |
2 |
2015 |
| Drug |
bay94-8862 |
2 |
2013 |
| Drug |
bia 5-1058 |
2 |
2018 |
| Behavioral |
bluetooth scale |
2 |
2016 |
| Procedure |
cabg surgery |
2 |
2015 |
| Device |
cardiac resynchronization therapy (crt) |
2 |
2015 |
| Device |
cardiac resynchronization therapy defibrillator |
2 |
2017 |
| Device |
cardiac resynchronization therapy with defibrillation |
2 |
2006 |
| Diagnostic Test |
cardiopulmonary exercise test |
2 |
2013 |
| Device |
carillon mitral contour system |
2 |
2017 |
| Drug |
cholecalciferol |
2 |
2011 |
| Drug |
ck-1827452 |
2 |
2009 |
| Behavioral |
clinical reminder |
2 |
2012 |
| Drug |
clp |
2 |
2012 |
| Behavioral |
combined aerobic |
2 |
2018 |
| Drug |
conivaptan |
2 |
2012 |
| Device |
continuous positive airway pressure (cpap) |
2 |
2017 |
| Device |
control lvad |
2 |
2010 |
| Biological |
control solution |
2 |
2015 |
| Drug |
conventional strategy |
2 |
2016 |
| Drug |
cor-1 |
2 |
2010 |
| Device |
cordellaâ„¢ pulmonary artery sensor system |
2 |
2019 |
| Device |
crt-p |
2 |
2010 |
| Device |
crt implant |
2 |
2013 |
| placebo |
dapagliflozin matching placebo |
2 |
2017 |
| Behavioral |
dash |
2 |
2014 |
| Drug |
dopamine |
2 |
2010 |
| Device |
doppler echocardiography |
2 |
2020 |
| Other |
ecg |
2 |
2014 |
| Other |
echocardiogram |
2 |
2013 |
| Drug |
elamipretide |
2 |
2016 |
| Device |
electrocardiogram |
2 |
2012 |
| Behavioral |
electronic pill bottle |
2 |
2016 |
| Behavioral |
engagement incentives |
2 |
2016 |
| Drug |
entresto |
2 |
2019 |
| Behavioral |
exercise only |
2 |
2014 |
| Behavioral |
exercise training program |
2 |
2015 |
| Drug |
fentanyl |
2 |
2015 |
| Drug |
ferinject (ferric carboxymaltose) |
2 |
2011 |
| Behavioral |
flexibility |
2 |
2014 |
| Diagnostic Test |
frailty assessment |
2 |
2018 |
| Drug |
furosemide injection solution for subcutaneous administration (80 mg) |
2 |
2014 |
| Drug |
furosemide injection, usp |
2 |
2014 |
| Behavioral |
gentle stretching |
2 |
2019 |
| Device |
health coaching |
2 |
2014 |
| Behavioral |
heart failure education |
2 |
2020 |
| Device |
heartmate 3 lvas |
2 |
2016 |
| Device |
heartpodâ„¢ system |
2 |
2008 |
| Device |
heartwareâ® vas |
2 |
2010 |
| Procedure |
hemodynamic measurements for crt device programming |
2 |
2013 |
| Behavioral |
high intensity interval training |
2 |
2014 |
| Behavioral |
hiit |
2 |
2019 |
| Drug |
hno donor |
2 |
2017 |
| Behavioral |
home-based exercise training |
2 |
2011 |
| Behavioral |
home based education |
2 |
2009 |
| Drug |
hydralazine |
2 |
2010 |
| Drug |
hydrochlorothiazide |
2 |
2019 |
| Behavioral |
icardia4hf |
2 |
2020 |
| Device |
implantable cardioverter-defibrillator (icd) |
2 |
2016 |
| Device |
implantable cardioverter defibrillator |
2 |
2014 |
| Drug |
inactivated trivalent influenza vaccine |
2 |
2013 |
| Drug |
insulin |
2 |
2010 |
| Behavioral |
interval training |
2 |
2015 |
| Drug |
intravenous insulin |
2 |
2008 |
| Drug |
irbesartan |
2 |
2006 |
| Drug |
kw-3902iv |
2 |
2005 |
| Other |
laboratory biomarker analysis |
2 |
2011 |
| Drug |
lcz 696 |
2 |
2019 |
| placebo |
lcz696 matching placebo |
2 |
2016 |
| Device |
left ventricular assist system (lvas) |
2 |
2014 |
| Drug |
levosimendan 2.5 mg |
2 |
2018 |
| Drug |
levothyroxine |
2 |
2016 |
| Drug |
liothyronine/placebo |
2 |
2019 |
| Drug |
losartan |
2 |
2013 |
| Behavioral |
low-intensity imt |
2 |
2017 |
| Other |
low sodium diet |
2 |
2018 |
| Drug |
medical management |
2 |
2015 |
| Device |
medly |
2 |
2017 |
| Drug |
metformin hydrochloride |
2 |
2017 |
| Drug |
metolazone |
2 |
2019 |
| Drug |
metoprolol |
2 |
2018 |
| Drug |
metoprolol succinate |
2 |
2013 |
| Behavioral |
mobile application |
2 |
2019 |
| Behavioral |
moderate continuous training |
2 |
2009 |
| Behavioral |
moderate intensity exercise training |
2 |
2014 |
| Behavioral |
motivational interviewing |
2 |
2017 |
| Biological |
mpc intramyocardial injection |
2 |
2015 |
| Procedure |
mri |
2 |
2015 |
| Drug |
neladenoson bialanate (bay1067197) |
2 |
2016 |
| Device |
neuromuscular electrical stimulation |
2 |
2020 |
| Dietary Supplement |
nicotinamide riboside |
2 |
2018 |
| Dietary Supplement |
nitrate-deplete beetroot juice |
2 |
2014 |
| Drug |
nitric oxide |
2 |
2012 |
| Other |
no intervention |
2 |
2011 |
| Other |
noninvasive ventilation |
2 |
2014 |
| Dietary Supplement |
normal sodium diet |
2 |
2018 |
| Device |
optimal medical therapy/crt/icd |
2 |
2013 |
| Device |
optimal medical therapy/icd |
2 |
2013 |
| Device |
optimizer system |
2 |
2011 |
| Drug |
perhexiline |
2 |
2009 |
| placebo |
placebo infusion |
2 |
2014 |
| Behavioral |
pp-based health behavior intervention |
2 |
2017 |
| Other |
preparation |
2 |
2012 |
| Behavioral |
psychoeducational support |
2 |
2015 |
| Device |
ptma (percutaneous transvenous mitral annuloplasty) implant |
2 |
2007 |
| Other |
pulmonary function tests |
2 |
2011 |
| Procedure |
pulmonary vein isolation |
2 |
2020 |
| Other |
quality-of-life assessment |
2 |
2011 |
| Other |
questionnaire |
2 |
2011 |
| Other |
questionnaire administration |
2 |
2011 |
| Procedure |
radiofrequency ablation |
2 |
2008 |
| Drug |
ramipril |
2 |
2009 |
| Drug |
relaxin |
2 |
2007 |
| Other |
resistance exercise |
2 |
2014 |
| Drug |
resveratrol |
2 |
2013 |
| Drug |
rivaroxaban |
2 |
2013 |
| Drug |
saccharomyces boulardii |
2 |
2011 |
| Drug |
sacubitril/valsartan (lcz696) |
2 |
2015 |
| Device |
saline solution |
2 |
2019 |
| Combination Product |
sc2wear furosemide |
2 |
2016 |
| Drug |
simvastatin |
2 |
2010 |
| Other |
sip feeding with stable isotope infusion |
2 |
2016 |
| Drug |
sodium nitrite |
2 |
2016 |
| Drug |
somatotropin |
2 |
2012 |
| Drug |
spironolactone / furosemide |
2 |
2008 |
| Drug |
spironolactone 25mg |
2 |
2010 |
| Drug |
splanchnic nerve anesthesia with a local anesthetic |
2 |
2018 |
| Device |
standard biventricular pacing |
2 |
2016 |
| Other |
standard imaging |
2 |
2011 |
| Drug |
standard medical therapy |
2 |
2011 |
| Drug |
standard of care for heart failure |
2 |
2015 |
| Other |
strength training |
2 |
2017 |
| Behavioral |
stretching |
2 |
2014 |
| Drug |
subcutaneous insulin |
2 |
2008 |
| Drug |
sugar pill |
2 |
2009 |
| Behavioral |
support |
2 |
2007 |
| Behavioral |
support partner |
2 |
2016 |
| Device |
tele-monitoring |
2 |
2015 |
| Behavioral |
telephone care |
2 |
2005 |
| Drug |
testosterone undecanoate |
2 |
2017 |
| Drug |
tezosentan |
2 |
2007 |
| Behavioral |
therapeutic education |
2 |
2016 |
| Drug |
torsemide |
2 |
2017 |
| Drug |
trv120027 |
2 |
2011 |
| Device |
tvs |
2 |
2017 |
| Behavioral |
usual heart failure care |
2 |
2012 |
| Drug |
valsartan (lcz696) |
2 |
2015 |
| Drug |
vericiguat (bay1021189) (1.25 mg) |
2 |
2013 |
| Drug |
vericiguat (bay1021189) (5 mg) |
2 |
2013 |
| Behavioral |
virtual visit |
2 |
2018 |
| Behavioral |
walking |
2 |
2014 |
| Drug |
warfarin |
2 |
2016 |
| Other |
water immersion |
2 |
2016 |
| Device |
NA |
1 |
2018 |
| Drug |
- angiotensin conversing enzyme inhibitors: enalapril, captopril, lisinopril, ramipril, trandolapril. |
1 |
2011 |
| Other |
“as usual” patient care management |
1 |
2016 |
| Drug |
“drug:carvedilol” |
1 |
2010 |
| Drug |
“drug:carvedilol”/“drug:ivabradine” |
1 |
2010 |
| Drug |
“drug:ivabradine” |
1 |
2010 |
| Device |
“in-clinic lvat” |
1 |
2016 |
| Drug |
[11c]hed |
1 |
2016 |
| Drug |
[13n]ammonia |
1 |
2016 |
| Drug |
[18f]3f-phpg |
1 |
2016 |
| Drug |
[18f]4f-mhpg |
1 |
2016 |
| Drug |
[18f]fluorbetaox |
1 |
2012 |
| Other |
[c11]acetate |
1 |
2014 |
| Other |
[c11]acetate/hed pet |
1 |
2014 |
| Drug |
0.005) |
1 |
2007 |
| Drug |
0.01) |
1 |
2007 |
| Drug |
0.5m sodium lactate |
1 |
2013 |
| Drug |
0.9 % sodium chloride |
1 |
2011 |
| Drug |
0.9% sodium chloride |
1 |
2019 |
| Drug |
0.9% sodium chloride injection |
1 |
2011 |
| Drug |
10 mg ir tablets |
1 |
2018 |
| Radiation |
11c-metformin |
1 |
2017 |
| Behavioral |
12-week education program |
1 |
2005 |
| Procedure |
12-week supervised weight loss intervention |
1 |
2011 |
| Behavioral |
12-week tai chi program |
1 |
2005 |
| Drug |
14 n sodium nitrite |
1 |
2015 |
| Drug |
14n nitrate |
1 |
2016 |
| Drug |
15n nitrate |
1 |
2016 |
| Device |
2-lead crt defibrillator system implantation |
1 |
2018 |
| Drug |
2.5 times the diuretics dose |
1 |
2016 |
| Drug |
2:1 epa |
1 |
2014 |
| Drug |
2:1 epa/dha |
1 |
2014 |
| Drug |
25 mg omecamtiv mecarbil |
1 |
2016 |
| Drug |
3 hours intravenous dobutamine |
1 |
2010 |
| Biological |
3 x 10e13vg nan-101 |
1 |
2019 |
| Drug |
30 ng |
1 |
2010 |
| Drug |
37.5 mg omecamtiv mecarbil |
1 |
2016 |
| Procedure |
3d echo-guided lv lead placement |
1 |
2011 |
| Device |
4 |
1 |
2005 |
| Drug |
4 mg elamipretide |
1 |
2016 |
| Drug |
40 mg elamipretide |
1 |
2016 |
| Device |
4he crt-d |
1 |
2005 |
| Drug |
5% glucose injection |
1 |
2014 |
| Drug |
50 mg omecamtiv mecarbil |
1 |
2016 |
| Procedure |
6 minute walk test |
1 |
2015 |
| Behavioral |
6 months readmission rate to hospital |
1 |
2006 |
| Device |
70cc tah-t for destination therapy |
1 |
2014 |
| Drug |
99mtc-pyp |
1 |
2018 |
| Other |
a motivational intervention |
1 |
2007 |
| Device |
âµcor |
1 |
2018 |
| Procedure |
aadc therapy |
1 |
2015 |
| Genetic |
aav1 |
1 |
2012 |
| Genetic |
aav1/serca2a (mydicar) |
1 |
2012 |
| Device |
abbott medicalâ® crt device with biventricular stimulation (biv) |
1 |
2019 |
| Device |
abbott medicalâ® crt device with syncavtm stimulation function |
1 |
2019 |
| Other |
abdominal magnetic resonance imaging |
1 |
2012 |
| Device |
ablation |
1 |
2020 |
| Drug |
ac2592 |
1 |
2004 |
| Dietary Supplement |
acacia gum |
1 |
2018 |
| Device |
accelerometer |
1 |
2016 |
| Device |
accelerometer mode on biotronik crt-d |
1 |
2015 |
| Behavioral |
acces - adjusting to chronic conditions with education |
1 |
2007 |
| Behavioral |
acces - adjusting to chronic conditions with education/support |
1 |
2007 |
| Behavioral |
access |
1 |
2010 |
| Device |
access arm |
1 |
2008 |
| Device |
accucinchâ® ventricular repair |
1 |
2018 |
| Device |
ace compression wrap |
1 |
2019 |
| Drug |
ace inhibitor - ramipril, enalapril, captopril, perindopril, lisinopril |
1 |
2006 |
| Drug |
acei/arb |
1 |
2019 |
| Drug |
acetylsalicylic acid (asa) therapy |
1 |
2016 |
| Drug |
acipimox |
1 |
2007 |
| Device |
acoustic cardiography |
1 |
2007 |
| Behavioral |
acp |
1 |
2014 |
| Behavioral |
acp video program |
1 |
2015 |
| Device |
acrt off |
1 |
2019 |
| Device |
acrt on |
1 |
2019 |
| Biological |
acrx-100 |
1 |
2010 |
| Other |
action control education |
1 |
2008 |
| Procedure |
activation of the vagus nerve stimulator |
1 |
2007 |
| Dietary Supplement |
active lozenge |
1 |
2017 |
| Drug |
active medication alone |
1 |
2001 |
| Behavioral |
active patient engagement |
1 |
2019 |
| Other |
active phototherapy |
1 |
2017 |
| Behavioral |
activity feedback |
1 |
2014 |
| Behavioral |
activity feedback/encouragement |
1 |
2014 |
| Drug |
actos |
1 |
2007 |
| Diagnostic Test |
acute hemodynamic study |
1 |
2020 |
| Other |
acute response assessment |
1 |
2013 |
| Drug |
ad5.hac6 |
1 |
2008 |
| Device |
adaptive crt (acrt) |
1 |
2009 |
| Procedure |
adaptive servo-ventilation post-operative treatment for 6 months |
1 |
2012 |
| Device |
adaptive servoventilation (asv) |
1 |
2010 |
| Device |
additional endocardial |
1 |
2010 |
| Device |
additional endocardial/epicardial lv lead |
1 |
2010 |
| Other |
additional phone calls |
1 |
2010 |
| Behavioral |
adherence measurements |
1 |
2016 |
| Behavioral |
adherence measures |
1 |
2014 |
| Behavioral |
adhesion-hf |
1 |
2014 |
| Other |
adjust to illness |
1 |
2011 |
| Drug |
adrecizumab |
1 |
2020 |
| Drug |
adrenergic beta antagonists |
1 |
1999 |
| Other |
advanced cardiac imaging |
1 |
2010 |
| Behavioral |
advanced care planning program of health decisions |
1 |
2020 |
| Other |
aerobic-inspiratory |
1 |
2016 |
| Other |
aerobic-resistance |
1 |
2016 |
| Other |
aerobic-resistance-inspiratory |
1 |
2016 |
| Behavioral |
aerobic exercise |
1 |
2015 |
| Other |
aerobic exercise in treadmill |
1 |
2016 |
| Behavioral |
aerobic exercise intervention |
1 |
2018 |
| Other |
aerobic exercise more force |
1 |
2019 |
| Behavioral |
aerobic exercise program |
1 |
2007 |
| Other |
aerobic/inspiratory training |
1 |
2018 |
| Other |
aerobic/strength training |
1 |
2013 |
| Procedure |
af ablation |
1 |
2008 |
| Drug |
afterload decrement |
1 |
2007 |
| Drug |
ai-700 |
1 |
2005 |
| Other |
ai-enabled ecg-based screening tool |
1 |
2019 |
| Device |
airsenseâ„¢ 10 autoset |
1 |
2016 |
| Drug |
albuterol |
1 |
2016 |
| Drug |
alcoholic chlorhexidine |
1 |
2013 |
| Drug |
alcoholic povidone iodine |
1 |
2013 |
| Drug |
aldosterone antagonists - spironolactone |
1 |
2006 |
| Drug |
aleglitazar |
1 |
2007 |
| Device |
alexa |
1 |
2018 |
| Device |
alexa/ |
1 |
2018 |
| Device |
alfapump dsr system |
1 |
2019 |
| Device |
algisyl-lvr |
1 |
2011 |
| Drug |
aliskiren 150 mg |
1 |
2010 |
| Drug |
aliskiren 300 mg |
1 |
2010 |
| Other |
all antidiabetic drugs will be appliable |
1 |
2010 |
| Other |
all patients |
1 |
2017 |
| Biological |
allogeneic adipose derived stem cells (cscc_asc) |
1 |
2014 |
| Biological |
allogeneic derived cells |
1 |
2016 |
| Drug |
allogeneic mesenchymal bone marrow cells (ambmc) |
1 |
2015 |
| Biological |
allogeneic mesenchymal precursor cells (mpc) |
1 |
2014 |
| Biological |
allogeneic stem cells implantation |
1 |
2012 |
| Behavioral |
ambio health remote monitoring |
1 |
2017 |
| Other |
ambulatory blood pressure monitoring |
1 |
2012 |
| Other |
ambulatory visit |
1 |
2018 |
| Drug |
amg 423 |
1 |
2015 |
| Drug |
amg 986 |
1 |
2017 |
| Drug |
anakinra (high dose) |
1 |
2013 |
| Drug |
anakinra (standard dose) |
1 |
2013 |
| Drug |
anakinra (weeks 1-2) |
1 |
2013 |
| Drug |
anakinra (weeks 3-12) |
1 |
2013 |
| Device |
anger camera |
1 |
2015 |
| Drug |
angiotensin-(1-7) |
1 |
2016 |
| Behavioral |
animal-assisted therapy |
1 |
2006 |
| Procedure |
anterior pericardiotomy |
1 |
2017 |
| Diagnostic Test |
anthropometry |
1 |
2020 |
| Diagnostic Test |
anthropometry/body composition |
1 |
2020 |
| Drug |
anti-arrhythmic therapy |
1 |
2015 |
| Device |
anti-factor xa guided heparin management |
1 |
2017 |
| Drug |
anti-myocardial remodeling |
1 |
2016 |
| Drug |
anti-myocardial remodeling,anti-acute heart failure |
1 |
2016 |
| Other |
anticoagulation care |
1 |
2017 |
| Dietary Supplement |
antioxidant |
1 |
2017 |
| Behavioral |
app group |
1 |
2018 |
| Device |
appli |
1 |
2019 |
| Behavioral |
application of a management action plan |
1 |
2005 |
| Device |
application of quadripolar |
1 |
2012 |
| Device |
application of quadripolar / bipolar lv electrodes |
1 |
2012 |
| Device |
aptt guided heparin management |
1 |
2017 |
| Device |
aquadex flexflow system |
1 |
2019 |
| Device |
aquadex flexflow system/bva-100 |
1 |
2019 |
| Device |
aquadex system |
1 |
2005 |
| Drug |
arb |
1 |
2019 |
| Device |
ardian |
1 |
2012 |
| Device |
arfi measurement |
1 |
2010 |
| Device |
assessment of burden of chronic conditions (abcc)-tool |
1 |
2019 |
| Diagnostic Test |
assessment of cardiac sympathetic innervation by 123i-mibg |
1 |
2018 |
| Other |
assessment of sleep apnea syndrome |
1 |
2012 |
| Other |
assistance by a specialized hf nurse |
1 |
2016 |
| Device |
asv |
1 |
2007 |
| Drug |
atacand tablet |
1 |
2012 |
| Other |
atrial fibrillation |
1 |
2014 |
| Procedure |
atrial fibrillation ablation |
1 |
2008 |
| Device |
atrial flow regulator (occlutechâ® afr device) |
1 |
2020 |
| Device |
atrial overdrive pacing |
1 |
2005 |
| Device |
atrial shunt |
1 |
2019 |
| Device |
atrial support pacing through cardiac resynchronization therapy. device: renewal family of crt-d devices |
1 |
2005 |
| Device |
atrial synchronous bi-ventricular pacing |
1 |
2006 |
| Procedure |
atrio ventricular junction ablation with radio-frequency |
1 |
2010 |
| Device |
attain stability quad left ventricular pacing lead |
1 |
2017 |
| Behavioral |
attention control (ac) condition |
1 |
2006 |
| Behavioral |
attention control group |
1 |
2012 |
| placebo |
attention placebo |
1 |
2005 |
| Device |
auto adjusting bi-level positive airway pressure device |
1 |
2008 |
| Procedure |
autologous bone marrow intracoronary infusion |
1 |
2009 |
| Biological |
autologous cell therapy |
1 |
2015 |
| Biological |
autologous human bone marrow cells (hbmcs) |
1 |
2008 |
| Biological |
autologous human mesenchymal cells (hmscs) |
1 |
2008 |
| Device |
automated medication dispensing device |
1 |
2012 |
| Device |
automatic fluid shunt system |
1 |
2009 |
| Device |
autotitrating positive airway pressure |
1 |
2008 |
| Device |
av delay programming through cardiac resynchronization therapy |
1 |
2008 |
| Procedure |
av nodal ablation |
1 |
2012 |
| Drug |
avanclia (rosiqlitazone) |
1 |
2003 |
| Drug |
avandia (rosiglitazone) |
1 |
2003 |
| Procedure |
avatar-af ablation |
1 |
2015 |
| Device |
avd-glittre test |
1 |
2015 |
| Drug |
azd4831 |
1 |
2020 |
| Drug |
azd8601 |
1 |
2017 |
| Drug |
azimilide 2hcl |
1 |
2008 |
| Drug |
azosemide |
1 |
2006 |
| Drug |
b-type natriuretic peptide (bnp) |
1 |
2005 |
| Other |
balance intervention |
1 |
2015 |
| Other |
balance training |
1 |
2019 |
| Other |
basic metabolic panel |
1 |
2015 |
| Drug |
bay 1753011 |
1 |
2019 |
| Drug |
bay1067197 |
1 |
2014 |
| Drug |
bay1067197 (10 mg) |
1 |
2014 |
| Drug |
bay1067197 (treatment 2) |
1 |
2013 |
| Drug |
bay60-4552 |
1 |
2007 |
| Drug |
bay94-8862 (1.25mg) |
1 |
2012 |
| Drug |
bay94-8862 (10mg) |
1 |
2012 |
| Drug |
bay94-8862 (2.5mg) |
1 |
2012 |
| Drug |
bay94-8862 (5mg) |
1 |
2012 |
| Drug |
bay94-8862 (7.5mg) |
1 |
2012 |
| Drug |
bc 007 |
1 |
2019 |
| Dietary Supplement |
bcaa supplementation |
1 |
2014 |
| Dietary Supplement |
beetroot juice (brj) |
1 |
2012 |
| Behavioral |
behavior) |
1 |
2006 |
| Behavioral |
behavioral |
1 |
2006 |
| Behavioral |
behavioral activation therapy |
1 |
2018 |
| Behavioral |
behavioral management |
1 |
2001 |
| Behavioral |
behavioral psychotherapy |
1 |
2006 |
| Behavioral |
behavioral support |
1 |
2015 |
| Behavioral |
benson relaxation exercise |
1 |
2020 |
| Drug |
benzbromarone (drug) |
1 |
2007 |
| Behavioral |
besmile-hf program |
1 |
2017 |
| Other |
best medical treatment |
1 |
2008 |
| Drug |
beta-blocker treatment |
1 |
2005 |
| Drug |
beta-blockers including carvedilol |
1 |
2006 |
| Drug |
beta-hydroxy-butyrate |
1 |
2018 |
| Drug |
beta adrenergic blockers |
1 |
2000 |
| Drug |
beta blocker |
1 |
2010 |
| Drug |
beta blocker (bb) - metoprolol, bisoprolol, carvedilol |
1 |
2006 |
| Drug |
beta blocker/digoxine/amiodarone |
1 |
2010 |
| Drug |
beta blockers |
1 |
2014 |
| Device |
beutel tm |
1 |
2008 |
| Device |
bi-ventricular pacing |
1 |
2017 |
| Device |
bi ventricular pacing |
1 |
2009 |
| Drug |
bia-5-453 |
1 |
2017 |
| Drug |
bidil |
1 |
2002 |
| Drug |
bidil immediate release (ir) |
1 |
2015 |
| Drug |
bidil xr |
1 |
2015 |
| Procedure |
bilateral surgical resection of carotid bodies |
1 |
2013 |
| Device |
bilevel |
1 |
2014 |
| Device |
bilevel positive pressure airway |
1 |
2016 |
| Device |
biobeat wrist watch |
1 |
2020 |
| Other |
bioimpedentiometry |
1 |
2015 |
| Biological |
biomarker |
1 |
2017 |
| Other |
biomarker guided discharge algorithm |
1 |
2017 |
| Device |
biomaterial |
1 |
2016 |
| Other |
biotechcoachforall |
1 |
2019 |
| Device |
biotronik vision guidewire |
1 |
2017 |
| Procedure |
bip group |
1 |
2011 |
| Device |
bipolar lv electrodes |
1 |
2012 |
| Device |
biv icd |
1 |
2010 |
| Device |
biventricular pacemaker |
1 |
2017 |
| Device |
biventricular pacemaker with epicardial left ventricular lead |
1 |
2007 |
| Device |
biventricular pacing |
1 |
2009 |
| Procedure |
blood collection |
1 |
2019 |
| Device |
blood flow restriction |
1 |
2017 |
| Device |
blood pressure |
1 |
2015 |
| Other |
blood sampling for biomarker assessment |
1 |
2015 |
| Other |
blood sampling/quality of life questionnaire. |
1 |
2018 |
| Other |
blood test |
1 |
2011 |
| Procedure |
blood volume analysis |
1 |
2019 |
| Procedure |
blood volume measurement |
1 |
2014 |
| Other |
blood withdrawal |
1 |
2017 |
| Device |
bmac infusion |
1 |
2011 |
| Drug |
bms-986224 |
1 |
2018 |
| Drug |
bms-986231 formulation a |
1 |
2019 |
| Drug |
bms-986231 formulation b |
1 |
2019 |
| Drug |
bms-986231 formulation c |
1 |
2019 |
| Drug |
bms-986231 formulation d |
1 |
2019 |
| placebo |
bms-986231 placebo |
1 |
2016 |
| Drug |
bnp |
1 |
2009 |
| Device |
bnp heartcheck |
1 |
2014 |
| Procedure |
bnp, saag, ascites total protein, echocardiography |
1 |
2010 |
| Drug |
bnp/pde-v |
1 |
2009 |
| Diagnostic Test |
body composition |
1 |
2020 |
| Device |
body composition analysis inbody scale |
1 |
2011 |
| Device |
body surface ecg mapping |
1 |
2013 |
| Procedure |
bone marrow transplantation |
1 |
2005 |
| Dietary Supplement |
boost high protein |
1 |
2013 |
| Drug |
bosentan |
1 |
2009 |
| Device |
boss device |
1 |
2017 |
| Drug |
bq-123 |
1 |
2014 |
| Device |
brain natriuretic peptide levels – diagnostic testing |
1 |
2007 |
| Other |
breathing technique |
1 |
2017 |
| Behavioral |
brief cognitive therapy intervention |
1 |
2011 |
| Behavioral |
brief educational intervention (bei) |
1 |
2006 |
| Behavioral |
brief treatment for insomnia |
1 |
2018 |
| Drug |
bucindolol hydrochloride |
1 |
2013 |
| Drug |
bumetanide 1 mg |
1 |
2018 |
| Behavioral |
burst physical activity |
1 |
2017 |
| Device |
bva-100 |
1 |
2019 |
| Biological |
c-cure |
1 |
2008 |
| Biological |
c-kit |
1 |
2015 |
| Biological |
c-kit/ cells |
1 |
2015 |
| Device |
c-pulseâ„¢ (implantable counterpulsation therapy) |
1 |
2008 |
| Device |
c-pulseâ® system counterpulsation |
1 |
2012 |
| Procedure |
cabg |
1 |
2001 |
| Procedure |
cabg surgery/med |
1 |
2001 |
| Procedure |
cabg/med/svr |
1 |
2001 |
| Drug |
canagliflozin |
1 |
2016 |
| Drug |
canagliflozin 100 mg |
1 |
2020 |
| Drug |
candemore tablet |
1 |
2012 |
| Drug |
candesartan up to 32 mg daily |
1 |
2006 |
| Drug |
canrenone |
1 |
2006 |
| Drug |
captopril |
1 |
2006 |
| placebo |
carbohydrate placebo |
1 |
2019 |
| Other |
cardiac |
1 |
2012 |
| Procedure |
cardiac catheterization |
1 |
2020 |
| Other |
cardiac computed tomography |
1 |
2016 |
| Other |
cardiac exercise training |
1 |
2016 |
| Other |
cardiac function indices during wakefulness |
1 |
2015 |
| Diagnostic Test |
cardiac magnetic resonance |
1 |
2017 |
| Diagnostic Test |
cardiac magnetic resonance, echocardiogram, blood investigation (nt-probnp) |
1 |
2019 |
| Diagnostic Test |
cardiac magnetic resonance, echocardiogram, blood investigation (nt-probnp), cardiac catheterization |
1 |
2019 |
| Device |
cardiac pacing |
1 |
2017 |
| Device |
cardiac pacing/impedance measurement system |
1 |
2017 |
| Other |
cardiac rehabilitation clinic |
1 |
2014 |
| Device |
cardiac resynchronisation therapy |
1 |
2015 |
| Device |
cardiac resynchronization pacemaker (insync sentry |
1 |
2008 |
| Device |
cardiac resynchronization pacemaker (insync sentry/concerto, medtronic, minneapolis, mn,usa) with two intracardiac leads |
1 |
2008 |
| Device |
cardiac resynchronization pacing |
1 |
2007 |
| Device |
cardiac resynchronization therapy-defibrillator (crt-d) |
1 |
2010 |
| Device |
cardiac resynchronization therapy -defibrillator (range paradym, livanova, clamart, france) |
1 |
2016 |
| Device |
cardiac resynchronization therapy (crt) device |
1 |
2005 |
| Device |
cardiac resynchronization therapy (crt) device/implantable cardioverter defibrillator (icd) with crt |
1 |
2005 |
| Procedure |
cardiac resynchronization therapy (crt) implantation |
1 |
2010 |
| Device |
cardiac resynchronization therapy (st. jude qaudripolar lv lead) |
1 |
2015 |
| Device |
cardiac resynchronization therapy defibrillator device |
1 |
2017 |
| Procedure |
cardiac resynchronization therapy device implantation |
1 |
2013 |
| Device |
cardiac resynchronization therapy device with closed loop stimulation (cls) |
1 |
2017 |
| Device |
cardiac resynchronization therapy implant |
1 |
2009 |
| Device |
cardiac resynchronization therapy implantation |
1 |
2016 |
| Device |
cardiac resynchronization therapy pacemaker |
1 |
2017 |
| Device |
cardiac resynchronization therapy pacemaker (crt-p) |
1 |
2018 |
| Device |
cardiac resynchronization therapy with |
1 |
2005 |
| Device |
cardiac resynchronization therapy with multipoint pacing |
1 |
2014 |
| Device |
cardiac resynchronization therapy with/without defibrillator |
1 |
2005 |
| Device |
cardiac resynchronization therapy/implantable cardioverter defibrillator |
1 |
2005 |
| Other |
cardiac/abdominal magnetic resonance imaging |
1 |
2012 |
| Other |
cardio-respiratory management model |
1 |
2016 |
| Drug |
cardiocell |
1 |
2018 |
| Device |
cardiocom |
1 |
2015 |
| Device |
cardiogoniometry |
1 |
2016 |
| Biological |
cardiology stem cell centre adipose stem cell (cscc_asc) |
1 |
2015 |
| Device |
cardiomems hf pressure measurement system |
1 |
2010 |
| Device |
cardiomems hf system |
1 |
2016 |
| Device |
cardiomemsâ„¢ hf system |
1 |
2017 |
| Diagnostic Test |
cardiopulmonary exercise testing |
1 |
2019 |
| Other |
cardiopulmonary max exercise test |
1 |
2015 |
| Device |
cardiopulmonary test |
1 |
2015 |
| Device |
cardiospec |
1 |
2010 |
| Device |
cardiospire (respirix) device |
1 |
2019 |
| Behavioral |
care guide |
1 |
2010 |
| Behavioral |
care management program “promic” |
1 |
2015 |
| Other |
care4todayheart failure platform |
1 |
2020 |
| Device |
carmat tah |
1 |
2016 |
| Procedure |
carotid body excision |
1 |
2012 |
| Other |
carotid ultrasound |
1 |
2008 |
| Drug |
carperitide |
1 |
2005 |
| Drug |
carvedilol-immediate release (ir) 2.5 mg tablet |
1 |
2008 |
| Drug |
carvedilol-ir 10 mg tablet |
1 |
2008 |
| Drug |
carvedilol controlled release |
1 |
2006 |
| Drug |
carvedilol immediate release |
1 |
2006 |
| Drug |
carvedilol/nurse management |
1 |
2006 |
| Other |
casa intervention |
1 |
2012 |
| Other |
case management |
1 |
2010 |
| Behavioral |
case management using advanced nurse practitioners |
1 |
2005 |
| Procedure |
catheter ablation for persistent atrial fibrillation |
1 |
2009 |
| Procedure |
catheterization, swan-ganz |
1 |
1999 |
| Procedure |
catheters |
1 |
2015 |
| Drug |
cd-np (chimeric natriuretic peptide) |
1 |
2008 |
| Drug |
cdr132l |
1 |
2019 |
| Device |
ce marked philips motiva system |
1 |
2014 |
| Device |
celacadeâ„¢ system |
1 |
2005 |
| Other |
cell phone |
1 |
2016 |
| Biological |
cell therapy |
1 |
2016 |
| Biological |
cells |
1 |
2015 |
| Device |
centrimag rvas placement |
1 |
2012 |
| Device |
centrimag ventricular assist system |
1 |
2009 |
| Other |
cf-lvad pump speed baseline. |
1 |
2014 |
| Other |
cf-lvad pump speed increased. |
1 |
2014 |
| Other |
change of treatment plan |
1 |
2018 |
| Other |
checklist cohort |
1 |
2011 |
| Other |
chemosensitivity test |
1 |
2015 |
| Other |
chest radiograph |
1 |
2011 |
| Other |
chest radiography |
1 |
2014 |
| Behavioral |
chf self-management education (web-based education) |
1 |
2001 |
| Device |
chiara-system |
1 |
2017 |
| Drug |
chlorothiazide |
1 |
2015 |
| Drug |
chlorothiazide injection |
1 |
2018 |
| Device |
chromed monitoring system |
1 |
2013 |
| Device |
chronic heart failure monitoring system |
1 |
2005 |
| Device |
chronicle implantable hemodynamic monitor |
1 |
2008 |
| Procedure |
circuit training |
1 |
2005 |
| Device |
circulite synergy pocket circulatory assist device |
1 |
2009 |
| Other |
classical cardiac rehabilitation |
1 |
2019 |
| Behavioral |
classical massage |
1 |
2020 |
| Other |
clean air |
1 |
2013 |
| Drug |
clevidipine |
1 |
2008 |
| Other |
clinical assessment |
1 |
2007 |
| Other |
clinical audit |
1 |
2016 |
| Other |
clinical audit/feedback |
1 |
2016 |
| Other |
clinical evaluation |
1 |
2019 |
| Other |
clinical evaluation in home monitoring program |
1 |
2011 |
| Other |
clinical pathways |
1 |
2007 |
| Other |
clinician nudge |
1 |
2018 |
| Other |
clinician nudge/opt out approach for ahcah liaison visit |
1 |
2018 |
| Drug |
clonidine patch |
1 |
2009 |
| Drug |
clopidogrel 75 |
1 |
2000 |
| Drug |
clopidogrel 75 mg daily x 2 weeks |
1 |
2012 |
| Drug |
clr325 |
1 |
2016 |
| Device |
cls mode on biotronik crt-d |
1 |
2015 |
| Diagnostic Test |
cmr |
1 |
2017 |
| Device |
cobas h232 (roche diagnostics) |
1 |
2016 |
| Dietary Supplement |
cocoavia |
1 |
2014 |
| Behavioral |
cognitive behavior therapy |
1 |
2009 |
| Behavioral |
cognitive behavioral therapy |
1 |
2005 |
| Behavioral |
cognitive behavioral therapy (cbt) |
1 |
2013 |
| Behavioral |
cognitive behavioral therapy for insomnia |
1 |
2016 |
| Behavioral |
cognitive behavioral therapy for insomnia (cbt-i) |
1 |
2016 |
| Behavioral |
cognitive behaviour therapy |
1 |
2012 |
| Behavioral |
cognitive retraining |
1 |
2014 |
| Other |
cognitive testing |
1 |
2016 |
| Behavioral |
cognitive training |
1 |
2015 |
| Other |
cohort |
1 |
2010 |
| Device |
cold cardioplegia solution |
1 |
2009 |
| Behavioral |
collaborative care for depression |
1 |
2014 |
| Behavioral |
collaborative care for heart failure |
1 |
2014 |
| Other |
collaborative care to alleviate symptoms |
1 |
2011 |
| Other |
collaborative care to alleviate symptoms/adjust to illness |
1 |
2011 |
| Behavioral |
collaborative care treatment |
1 |
2009 |
| Procedure |
collection of discarded heart tissue |
1 |
2017 |
| Behavioral |
color-coded cue cards |
1 |
2016 |
| Drug |
combination therapy with acetazolamide |
1 |
2013 |
| Drug |
combination therapy with acetazolamide/low-dose loop diuretics |
1 |
2013 |
| Other |
combined |
1 |
2018 |
| Other |
combined aerobic training |
1 |
2017 |
| Other |
combined aerobic/resistance physical training program |
1 |
2015 |
| Behavioral |
combined aerobic/strength exercise intervention |
1 |
2018 |
| Other |
combined ambulatory visit |
1 |
2018 |
| Behavioral |
combined psychotherapy |
1 |
2011 |
| Behavioral |
combined psychotherapy/illness management |
1 |
2011 |
| Other |
combined strength training |
1 |
2017 |
| Other |
comfort default ad forms |
1 |
2013 |
| Behavioral |
commitment nudge |
1 |
2018 |
| Behavioral |
communication training for cardiologists. |
1 |
2011 |
| Other |
community of practice facilitation |
1 |
2013 |
| Other |
community paramedicine |
1 |
2014 |
| Behavioral |
comorbid illness management |
1 |
2006 |
| placebo |
comparator placebo (unspecified) |
1 |
2008 |
| placebo |
comparator: placebo |
1 |
2008 |
| Device |
compare vvi mode versus ddd bifocal stimulation through crossover randomization |
1 |
2018 |
| Other |
composition of body mass by dual x-ray absorptiometry |
1 |
2012 |
| Behavioral |
comprehensive quality improvement program (qip) |
1 |
2010 |
| Behavioral |
computer reminders |
1 |
2001 |
| Behavioral |
computerized cognitive training with brain hq |
1 |
2017 |
| Behavioral |
computerized crossword puzzles |
1 |
2017 |
| Other |
concentric |
1 |
2014 |
| Other |
concentric aerobic exercise |
1 |
2014 |
| Other |
concentric/eccentric exercise sessions |
1 |
2014 |
| Device |
concerto, medtronic, minneapolis, mn,usa) with two intracardiac leads |
1 |
2008 |
| Device |
conductance catheter |
1 |
2016 |
| Device |
conductance catheterization |
1 |
2014 |
| Device |
contak renewal 2 |
1 |
2005 |
| Device |
contak renewal 2/4/4he crt-d |
1 |
2005 |
| Device |
contak renewal 3 avt |
1 |
2005 |
| Other |
continues aerobic training |
1 |
2013 |
| Other |
continuing medical education |
1 |
2019 |
| Other |
continuous aerobic training |
1 |
2020 |
| Device |
continuous positive airway pressure |
1 |
2013 |
| Behavioral |
continuous training |
1 |
2015 |
| Other |
control diet |
1 |
2014 |
| Other |
control group (standard care) |
1 |
2017 |
| Biological |
control procedure |
1 |
2016 |
| Device |
controlled cardiac reloading through lvad speed adjustment |
1 |
2017 |
| Drug |
controlled withdrawal of beta-blockers |
1 |
2019 |
| Other |
controlled, supervised exercise protocol |
1 |
2014 |
| Other |
conventional |
1 |
2020 |
| Device |
conventional 3-lead crt defibrillator system implantation |
1 |
2018 |
| Procedure |
conventional af ablation |
1 |
2015 |
| Device |
conventional cardiac resynchronization |
1 |
2009 |
| Other |
conventional care |
1 |
2014 |
| Device |
conventional crt |
1 |
2016 |
| Other |
conventional interval training |
1 |
2019 |
| Other |
conventional medical therapy for heart failure |
1 |
2008 |
| Other |
conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,/lopinavir/ritonavir)/traditional chinese medicines (tcms) granules |
1 |
2008 |
| Other |
conventional rhythm control |
1 |
2009 |
| Behavioral |
coping effectiveness training (cet) |
1 |
2015 |
| Behavioral |
coping skills training |
1 |
2009 |
| Drug |
coq10 |
1 |
2017 |
| Device |
cordellaâ„¢ heart failure system |
1 |
2017 |
| Device |
cordiva system (r) |
1 |
2014 |
| Device |
corollaâ„¢ taa device |
1 |
2015 |
| Procedure |
coronary artery bypass grafting |
1 |
2009 |
| Other |
coronary artery disease |
1 |
2013 |
| Device |
corox otw steroid left ventricular lead |
1 |
2006 |
| Behavioral |
cp |
1 |
2007 |
| Device |
cpap therapy |
1 |
2008 |
| Other |
cpr |
1 |
2013 |
| Drug |
crataegus special extract ws 1442 |
1 |
2006 |
| Drug |
crd-102 |
1 |
2017 |
| Drug |
crestor |
1 |
2005 |
| Other |
crt-d full remote monitoring |
1 |
2016 |
| Procedure |
crt-d implantation |
1 |
2018 |
| Device |
crt-d re-programming |
1 |
2018 |
| Other |
crt-d standard remote monitoring |
1 |
2016 |
| Device |
crt-d with home monitoring feature activated |
1 |
2007 |
| Device |
crt-d with home monitoring feature deactivated |
1 |
2007 |
| Device |
crt-d/lv lead (quartetâ„¢ lead/promote qâ® device system) |
1 |
2009 |
| Procedure |
crt-p implantation |
1 |
2018 |
| Device |
crt-p/crt-d |
1 |
2010 |
| Other |
crt-p/crt-d full remote monitoring |
1 |
2016 |
| Other |
crt-p/crt-d standard remote monitoring |
1 |
2016 |
| Device |
crt-sonr 9770 |
1 |
2010 |
| Device |
crt 9750 |
1 |
2010 |
| Device |
crt algorithm |
1 |
2016 |
| Device |
crt device implant with multipoint pacing |
1 |
2013 |
| Device |
crt pacemaker |
1 |
2016 |
| Device |
crt with lv-only pacing |
1 |
2017 |
| Device |
crt with lv-only pacing / bi-ventricular pacing |
1 |
2017 |
| Device |
crt with multipoint pacing |
1 |
2014 |
| Device |
crt with triple site ventricular stimulation |
1 |
2009 |
| Device |
crt/navh |
1 |
2016 |
| Procedure |
cryoballoon ablation |
1 |
2018 |
| Biological |
cscc_asc |
1 |
2016 |
| Other |
ct-scan |
1 |
2019 |
| Procedure |
ct angiography |
1 |
2006 |
| Drug |
custodiol |
1 |
2015 |
| Drug |
custodiol-n |
1 |
2015 |
| Drug |
cxl-1020 |
1 |
2010 |
| Drug |
cxl-1020 dose for echo cohort a |
1 |
2010 |
| Drug |
cxl-1020 doses for echo cohort b |
1 |
2010 |
| Drug |
cxl-1427 |
1 |
2014 |
| Drug |
cxl-1427 ascending dose |
1 |
2016 |
| Drug |
cxl-1427 descending dose |
1 |
2016 |
| Device |
czt camera (d-spect) |
1 |
2015 |
| Drug |
d-ribose oral powder |
1 |
2017 |
| Other |
daily ischemic conditioning treatment |
1 |
2014 |
| Other |
daily life. |
1 |
2013 |
| Behavioral |
daily physical activity |
1 |
2014 |
| Diagnostic Test |
daily pocus exam |
1 |
2019 |
| Behavioral |
daily weight measured by digital scale |
1 |
2011 |
| Behavioral |
daily weight measured by digital scale/symptom reporting |
1 |
2011 |
| Other |
danger signs of heart failure videos |
1 |
2018 |
| Drug |
dapagliflozin 10 mg [farxiga] |
1 |
2019 |
| Drug |
dapagliflozin 10mg oral tablet |
1 |
2017 |
| Drug |
dapansutrile capsules |
1 |
2017 |
| Other |
dash eating pattern |
1 |
2018 |
| Behavioral |
dash/sodium-restricted diet (srd) |
1 |
2009 |
| Other |
dash/srd |
1 |
2014 |
| Procedure |
dcd heart transplantation using nrp |
1 |
2020 |
| Procedure |
dce-mri scans |
1 |
2014 |
| Procedure |
ddd-60 |
1 |
2014 |
| Procedure |
ddd-80 |
1 |
2014 |
| Other |
decision support systems, clinical |
1 |
2019 |
| Device |
defibrillator |
1 |
2018 |
| Device |
defibrillators, implantable |
1 |
1999 |
| Drug |
definity |
1 |
2017 |
| Other |
delayed mbs intervention |
1 |
2015 |
| Drug |
demadex 20mg tablet |
1 |
2017 |
| Other |
deuterium oxide dilution |
1 |
2015 |
| Device |
device implantation |
1 |
2008 |
| Device |
device programming |
1 |
2009 |
| Device |
device programming of crt pacemaker |
1 |
2018 |
| Device |
device programming of crt pacemaker/defibrillator |
1 |
2018 |
| Other |
device programming: nominal |
1 |
2011 |
| Device |
device therapy for heart failure |
1 |
2013 |
| Behavioral |
device triggered remote telephone contact because of care alert |
1 |
2008 |
| Device |
device: attain performa pacing lead (along with a standard crt-d system) |
1 |
2012 |
| Radiation |
dexa |
1 |
2015 |
| Radiation |
dexa bone scan |
1 |
2015 |
| Drug |
dexamethasone |
1 |
2014 |
| Drug |
dexmedetomidine |
1 |
2015 |
| Drug |
dha |
1 |
2014 |
| Dietary Supplement |
dha) alone |
1 |
2014 |
| Device |
diagnostic electrophysiology catheter |
1 |
2010 |
| Procedure |
diagnostic ultrasound |
1 |
2016 |
| Device |
diaphragm ultrasound |
1 |
2015 |
| Procedure |
diastolic pressure at exercise |
1 |
2012 |
| Behavioral |
diet |
1 |
2009 |
| Behavioral |
diet/exercise |
1 |
2009 |
| Behavioral |
dietary counseling |
1 |
2008 |
| Dietary Supplement |
dietary intervention |
1 |
2009 |
| Other |
dietary manipulation |
1 |
2020 |
| Other |
dietary plan with controlled amount of sodium |
1 |
2015 |
| Behavioral |
dietary, |
1 |
2015 |
| Behavioral |
dietary, aerobic |
1 |
2015 |
| Behavioral |
dietary, aerobic/resistance training |
1 |
2015 |
| Behavioral |
dietary,/aerobic exercise |
1 |
2015 |
| Behavioral |
dietetic group sessions |
1 |
2014 |
| Device |
different programming of a crt defibrillator |
1 |
2017 |
| Device |
diffusion tensor mri (dti) |
1 |
2016 |
| Other |
digital engagement |
1 |
2017 |
| Other |
digital talking scale |
1 |
2013 |
| Drug |
digitalis |
1 |
1999 |
| Drug |
digoxin 0.25 mg |
1 |
2019 |
| Other |
digoxin dosing per nomogram |
1 |
2009 |
| Drug |
digoxine |
1 |
2010 |
| Other |
direct engagement |
1 |
2017 |
| Behavioral |
discharge education of chinese medicine |
1 |
2018 |
| Other |
discussion |
1 |
2016 |
| Behavioral |
discussion group |
1 |
2012 |
| Other |
disease management |
1 |
2007 |
| Other |
disease management program |
1 |
2010 |
| Other |
disease management/tele-monitoring |
1 |
2007 |
| Other |
disease program management |
1 |
2007 |
| Drug |
diuretic |
1 |
2017 |
| Drug |
diuretic increase (di) |
1 |
2017 |
| Drug |
diuretic suspension (ds) |
1 |
2017 |
| Drug |
diuretic/medication suspension (dms) |
1 |
2017 |
| Other |
dna extraction |
1 |
2010 |
| Other |
dna extraction/genotyping |
1 |
2010 |
| Device |
docview |
1 |
2015 |
| Device |
doppler-echocardiography |
1 |
2007 |
| Device |
doppler-echocardiography/acoustic cardiography |
1 |
2007 |
| Device |
doraya catheter |
1 |
2017 |
| Other |
doubly labelled water |
1 |
2008 |
| Other |
doubly labelled water/questionnaire |
1 |
2008 |
| Device |
dr 9550 |
1 |
2010 |
| Behavioral |
driving decision aid |
1 |
2019 |
| Drug |
drug therapy for heart failure |
1 |
2013 |
| Other |
drug therapy for hf |
1 |
2006 |
| Behavioral |
dt lvad decision support intervention |
1 |
2015 |
| Procedure |
dt pressure measurement |
1 |
2009 |
| Device |
dual (atrial |
1 |
2006 |
| Device |
dual (atrial/ventricular) implantable defibrillator |
1 |
2006 |
| Device |
dynaport move monitor |
1 |
2018 |
| Other |
dynasdy |
1 |
2015 |
| Dietary Supplement |
eaa mixture |
1 |
2018 |
| Procedure |
early intensive care bundle |
1 |
2018 |
| Combination Product |
early intra-aortic balloon pump (iabp) implantation |
1 |
2020 |
| Other |
early warning system monitoring. |
1 |
2012 |
| Device |
easytrak 2 lead |
1 |
2005 |
| Device |
easytrak 3 downsize lead |
1 |
2006 |
| Device |
easytrak 3 left ventricular pacing lead |
1 |
2005 |
| Device |
easytrak 4 steerable lv lead |
1 |
2005 |
| Device |
easytrak epi lead |
1 |
2005 |
| Other |
eccentric aerobic exercise |
1 |
2014 |
| Other |
eccentric exercise sessions |
1 |
2014 |
| Other |
eccentric rehabilitation sessions |
1 |
2018 |
| Device |
ecg belt research system |
1 |
2018 |
| Device |
ecg vest optimization |
1 |
2016 |
| Other |
ecg/clinical evaluation in home monitoring program |
1 |
2011 |
| Device |
echo |
1 |
2009 |
| Device |
echo-guided left ventricular lead placement |
1 |
2005 |
| Device |
echo-optimization |
1 |
2019 |
| Other |
echo optimisation |
1 |
2010 |
| Other |
echocardiogram/sonr |
1 |
2011 |
| Device |
echocardiograms |
1 |
2015 |
| Other |
echotracking |
1 |
2012 |
| Behavioral |
education only |
1 |
2010 |
| Behavioral |
education with teach-back method |
1 |
2018 |
| Behavioral |
education/care guide |
1 |
2010 |
| Behavioral |
educational intervention |
1 |
2006 |
| Behavioral |
educational program |
1 |
2001 |
| Other |
educational structured counseling |
1 |
2015 |
| Other |
educational training regarding heart failure |
1 |
2009 |
| Other |
educational video and |
1 |
2017 |
| Other |
educational video and/or handout |
1 |
2017 |
| Other |
educational website (in addition to usual care). |
1 |
2012 |
| Other |
effect of cpap on respiratory work |
1 |
2015 |
| Other |
effect of cpap on respiratory work/cardiac function indices during wakefulness |
1 |
2015 |
| Behavioral |
effects of a 2-week dash |
1 |
2017 |
| Behavioral |
effects of a 2-week dash/srd intervention vs. control diet on hfpef functional cardiovascular risk factors |
1 |
2017 |
| Behavioral |
ehr-based clinician jumpstart |
1 |
2020 |
| Procedure |
elastography function shearwave imaging |
1 |
2015 |
| Device |
electrical |
1 |
2014 |
| Device |
electrical muscle devise |
1 |
2018 |
| Device |
electrical/magnetic nerve stimulators |
1 |
2014 |
| Device |
electrocardiographic optimization of the interventricular pacing delay according to qrs width |
1 |
2010 |
| Behavioral |
electronic alert |
1 |
2019 |
| Behavioral |
electronic prescription |
1 |
2018 |
| Device |
electronic repositioning |
1 |
2008 |
| Procedure |
electrophysiological study |
1 |
2013 |
| Device |
elevated night pacing off |
1 |
2017 |
| Device |
elevated night pacing on |
1 |
2017 |
| Drug |
empagliflozin 10mg |
1 |
2017 |
| Drug |
empagliflozin 10mg tab |
1 |
2017 |
| Drug |
empagliflozin 25 mg |
1 |
2019 |
| Drug |
empagliflozin 25mg |
1 |
2017 |
| Behavioral |
enable chf-pc |
1 |
2017 |
| Behavioral |
encompass intervention |
1 |
2017 |
| Behavioral |
encouragement |
1 |
2014 |
| Device |
endocardial left ventricular pacing |
1 |
2011 |
| Behavioral |
endorsed evidence summaries |
1 |
2005 |
| Behavioral |
endurance training |
1 |
2009 |
| Other |
energy conservation |
1 |
2019 |
| Other |
energy conservation/problem solving therapy |
1 |
2019 |
| Behavioral |
enhanced education |
1 |
2012 |
| Device |
enhanced external counterpulsa |
1 |
2018 |
| Behavioral |
enhanced se |
1 |
2005 |
| Behavioral |
enhanced self-efficacy (se) |
1 |
2005 |
| Other |
enhanced standard management |
1 |
2013 |
| Behavioral |
enhanced training |
1 |
2012 |
| Behavioral |
enhanced usual care group |
1 |
2012 |
| Other |
ensite navx system |
1 |
2007 |
| Drug |
entrestoâ„¢ 49mg-51 mg tablet |
1 |
2018 |
| Other |
enzyme-linked immunosorbent assay |
1 |
2011 |
| Drug |
epclusa |
1 |
2017 |
| Device |
epicardial implantation of cardiac resynchronization therapy device |
1 |
2009 |
| Device |
epicardial lv lead |
1 |
2010 |
| Dietary Supplement |
epicatechin-enriched dark chocolate |
1 |
2012 |
| Device |
equiliaâ® vagal nerve stimulation |
1 |
2014 |
| Drug |
er torsemide 20mg tablet |
1 |
2017 |
| Procedure |
eric protocol |
1 |
2018 |
| Drug |
ertugliflozin |
1 |
2018 |
| Drug |
erythropoietin administration |
1 |
2006 |
| Drug |
erythropoietin alpha |
1 |
2006 |
| Drug |
etiologic treatment,anti-myocardial remodeling |
1 |
2016 |
| Drug |
etiological, anti-remodeling |
1 |
2016 |
| Drug |
etiological, anti-remodeling/symptom treatment |
1 |
2016 |
| Device |
europe: autoset cs (usa: vpap adapt sv) |
1 |
2008 |
| Device |
evaheart left ventricular assist system (lvas) |
1 |
2010 |
| Behavioral |
evaluation of quality of life health related |
1 |
2019 |
| Drug |
evidence-based medications |
1 |
2019 |
| Drug |
evidence-based medications vs. high-dose hydralazine |
1 |
2019 |
| Drug |
evidence-based medications vs. high-dose hydralazine / evidence-based medications |
1 |
2019 |
| Drug |
evolocumab |
1 |
2018 |
| Drug |
exenatide |
1 |
2008 |
| Behavioral |
exercise adherence |
1 |
2007 |
| Behavioral |
exercise group |
1 |
2019 |
| Other |
exercise protocol no supervised |
1 |
2014 |
| Other |
exercise rehabilitation |
1 |
2018 |
| Other |
exercise test |
1 |
2018 |
| Other |
exercise training and |
1 |
2013 |
| Other |
exercise training and/or crt |
1 |
2013 |
| Behavioral |
exercise training in heart failure with hiit |
1 |
2018 |
| Other |
exercise training intervention |
1 |
2017 |
| Other |
exercise training of high intensity |
1 |
2020 |
| Other |
exercise training of moderate intensity |
1 |
2020 |
| Other |
exercise with |
1 |
2020 |
| Other |
exercise with/without codeine |
1 |
2020 |
| Behavioral |
exercise, nutritional |
1 |
2015 |
| Behavioral |
exercise, nutritional/pharmaceutical counseling |
1 |
2015 |
| Behavioral |
exercise/cognitive retraining |
1 |
2014 |
| Other |
exercise/cognitive testing |
1 |
2016 |
| Other |
expanded technology disease management |
1 |
2014 |
| Device |
experimental |
1 |
2011 |
| Device |
experimental 2 |
1 |
2011 |
| Procedure |
experimental lung function test |
1 |
2007 |
| Device |
external electrocardioversion |
1 |
2014 |
| Behavioral |
facilitator-based intervention |
1 |
2018 |
| Behavioral |
family education |
1 |
2005 |
| Behavioral |
family focused nursing |
1 |
2011 |
| Behavioral |
family partnership intervention (fpi) |
1 |
2005 |
| Behavioral |
family swap intervention with mini ipad |
1 |
2015 |
| Behavioral |
fampalcare |
1 |
2019 |
| Device |
fatigue |
1 |
2020 |
| Device |
feasibility of wearing a readiband to monitor sleep |
1 |
2020 |
| Device |
feasibility of wearing a readiband to monitor sleep/fatigue |
1 |
2020 |
| Other |
feedback |
1 |
2016 |
| Drug |
ferinject â® (ferric carboxymaltose) |
1 |
2007 |
| Drug |
ferric carboxymaltose 50mg |
1 |
2017 |
| Drug |
ferric carboxymaltose 50mg/ml inj 15ml |
1 |
2017 |
| Drug |
ferric carboxymaltose infusion |
1 |
2016 |
| Drug |
ferric carboymaltose |
1 |
2017 |
| Drug |
ferric polymaltose hydroxide complex im |
1 |
2019 |
| Drug |
ferroglycine sulfate |
1 |
2019 |
| Drug |
ferrous sulfate |
1 |
2016 |
| Other |
fes |
1 |
2015 |
| Other |
filtered diesel exhaust |
1 |
2013 |
| Other |
final evaluation |
1 |
2014 |
| Device |
finapres nova device (fms system) |
1 |
2015 |
| Drug |
finerenone (bay94-8862) |
1 |
2013 |
| Device |
fire1 system |
1 |
2019 |
| Drug |
fish oil |
1 |
2014 |
| Dietary Supplement |
fish oil (epa |
1 |
2014 |
| Dietary Supplement |
fish oil (epa/dha) alone |
1 |
2014 |
| Drug |
fish oil supplement |
1 |
2004 |
| Drug |
fish oil supplementation |
1 |
2012 |
| Device |
fitbit charge 2 |
1 |
2019 |
| Behavioral |
five wishes form |
1 |
2018 |
| Device |
fixed av delay |
1 |
2019 |
| Procedure |
flexibility/toning |
1 |
2005 |
| Device |
florence device |
1 |
2018 |
| Biological |
flu vaccine |
1 |
2008 |
| Dietary Supplement |
fluid restriction |
1 |
2009 |
| Device |
fluid status monitoring (optivolâ„¢) |
1 |
2006 |
| Behavioral |
fluid watchers |
1 |
2006 |
| Behavioral |
fluid watchers lite educational intervention |
1 |
2006 |
| Behavioral |
fluid watchers/educational intervention |
1 |
2006 |
| Other |
fluoroscopy venography |
1 |
2017 |
| Diagnostic Test |
focused ultrasound diagnostics |
1 |
2018 |
| Other |
follow-up |
1 |
2013 |
| Drug |
frozen plasma product, human |
1 |
2017 |
| Drug |
frusemide |
1 |
2017 |
| Other |
frusemide iv infusion |
1 |
2019 |
| Other |
frusemide iv shots |
1 |
2019 |
| Radiation |
ftha, fdg pet imaging. |
1 |
2012 |
| Behavioral |
full simulation |
1 |
2013 |
| Behavioral |
full simulation/education |
1 |
2013 |
| Diagnostic Test |
functional capacity tests |
1 |
2020 |
| Behavioral |
functional circuit training |
1 |
2010 |
| Behavioral |
functional circuit training/lifestyle counseling |
1 |
2010 |
| Other |
functional electrical stimulation |
1 |
2013 |
| Other |
functional electrical stimulation of peripheral muscles |
1 |
2013 |
| Other |
functional training |
1 |
2017 |
| Other |
functionnal electrostimulation (fes) |
1 |
2012 |
| Drug |
furosemide-continuous infusion |
1 |
2007 |
| Drug |
furosemide-high intensification |
1 |
2007 |
| Drug |
furosemide-low intensification |
1 |
2007 |
| Drug |
furosemide-q12 hour bolus |
1 |
2007 |
| Drug |
furosemide 40 mg |
1 |
2019 |
| Drug |
furosemide 60 mg |
1 |
2010 |
| Drug |
furosemide infusion |
1 |
2011 |
| Drug |
furosemide injection solution (scp-101) |
1 |
2015 |
| Drug |
furosemide injection solution, usp |
1 |
2015 |
| Drug |
furosemide) |
1 |
2015 |
| Drug |
furosemide/hypertonic saline solution |
1 |
2009 |
| Drug |
furosemide/phone contact |
1 |
2014 |
| Drug |
fursemide injection solution for subcutaneous administration (80 mg) |
1 |
2014 |
| Other |
gadobutrol |
1 |
2014 |
| Drug |
gadolinium dota meglumine |
1 |
2016 |
| Drug |
gdmt |
1 |
2019 |
| Device |
gds accucinch system |
1 |
2014 |
| Drug |
ge-145 |
1 |
2010 |
| Behavioral |
generic dietary feedback from |
1 |
2012 |
| Other |
genotyping |
1 |
2010 |
| Behavioral |
gentle stretching/education |
1 |
2020 |
| Other |
geriatric intervention |
1 |
2018 |
| Drug |
ggf2 |
1 |
2013 |
| Drug |
gik |
1 |
2004 |
| Drug |
glial growth factor 2 |
1 |
2010 |
| Drug |
glial growth factor 2/ neuregulin 1î²3 |
1 |
2010 |
| Drug |
glimepiride |
1 |
2011 |
| Drug |
glp-1 |
1 |
2005 |
| Drug |
glucagon-like peptide 1 |
1 |
2014 |
| Drug |
glucocorticoid |
1 |
2009 |
| Other |
glucose tolerance test |
1 |
2012 |
| Drug |
glutamate infusion |
1 |
2015 |
| Drug |
glutamine |
1 |
2012 |
| Drug |
glutamine/fish oil supplementation |
1 |
2012 |
| Drug |
glycopyrrolate |
1 |
2015 |
| Drug |
goal-directed preload |
1 |
2007 |
| Drug |
goal-directed preload/afterload decrement |
1 |
2007 |
| Behavioral |
goals of care |
1 |
2014 |
| Device |
gore-tex dualmesh emerge |
1 |
2016 |
| Device |
gore-tex dualmesh emerge/biomaterial |
1 |
2016 |
| Behavioral |
gp’s treating hf according the dutch guidelines |
1 |
2012 |
| Drug |
granulocyte-colony stimulating factor |
1 |
2008 |
| Drug |
grape seed extract (meganatural bp, polyphenolics, inc.) |
1 |
2010 |
| Behavioral |
group-based skill building self-care program |
1 |
2013 |
| Behavioral |
group i: video training |
1 |
2005 |
| Behavioral |
group ii: video training |
1 |
2005 |
| Behavioral |
group ii: video training / enhanced self-efficacy (se) |
1 |
2005 |
| Behavioral |
group iii: in-person training |
1 |
2005 |
| Behavioral |
group iii: in-person training / enhanced se |
1 |
2005 |
| Behavioral |
group iv: in-person training |
1 |
2005 |
| Behavioral |
group iv: in-person training / enhanced se / support |
1 |
2005 |
| Behavioral |
group medical visits |
1 |
2015 |
| Drug |
growth hormone |
1 |
2007 |
| Drug |
growth hormone releasing hormone |
1 |
2008 |
| Drug |
growth hormone releasing hormone/ placebo |
1 |
2008 |
| Drug |
gsk2798745 |
1 |
2015 |
| Drug |
gsk2798745 capsule |
1 |
2014 |
| Drug |
gsk2798745 micronized api with sls |
1 |
2016 |
| Drug |
gsk2798745 micronized api with sls/hypermellose (tablet b) |
1 |
2016 |
| Drug |
gsk2798745 micronized api without sls |
1 |
2016 |
| Drug |
gsk2798745 micronized api without sls/hypermellose (tablet a) |
1 |
2016 |
| Drug |
gsk2798745 milled api without sls |
1 |
2016 |
| Drug |
gsk2798745 milled api without sls/hypermellose (tablet c) |
1 |
2016 |
| Drug |
gsk2798745 solution |
1 |
2014 |
| Drug |
gsk2798745 suspension |
1 |
2014 |
| Drug |
gsk716155 |
1 |
2010 |
| Behavioral |
gtelephone-administered cognitive-behavioral therapy (t-cbt) |
1 |
2001 |
| Behavioral |
guided-hf |
1 |
2015 |
| Other |
guideline-directed medical therapy |
1 |
2018 |
| Other |
guideline directed heart failure medication |
1 |
2017 |
| Other |
guideline directed therapy |
1 |
2017 |
| Other |
handled echocardiography in home monitoring program |
1 |
2011 |
| Device |
harmony system |
1 |
2015 |
| Drug |
hartmann’s solution |
1 |
2013 |
| Device |
health buddy system |
1 |
2007 |
| Other |
health coaching/home exercise |
1 |
2014 |
| Other |
health education intervention |
1 |
2019 |
| Behavioral |
health education/independent walking |
1 |
2010 |
| Behavioral |
health literacy-tailored education |
1 |
2007 |
| Behavioral |
healthy lifestyle |
1 |
2013 |
| Behavioral |
healthy lifestyle/sleep education |
1 |
2013 |
| Other |
heart-failure related pharmaceutical intervention |
1 |
2014 |
| Behavioral |
heart camp (hc) intervention group |
1 |
2012 |
| Behavioral |
heart camp group |
1 |
2012 |
| Behavioral |
heart care self tracker |
1 |
2009 |
| Other |
heart failure application |
1 |
2017 |
| Other |
heart failure disease management program |
1 |
2013 |
| Other |
heart failure diuretic decision support tool for patient self managementâ© |
1 |
2013 |
| Behavioral |
heart failure education/management app |
1 |
2017 |
| Behavioral |
heart failure group clinic appointments |
1 |
2007 |
| Other |
heart failure guidelines |
1 |
2016 |
| Behavioral |
heart failure literature |
1 |
2017 |
| Device |
heart failure remote patient monitoring system |
1 |
2008 |
| Other |
heart failure risk status diagnostic |
1 |
2011 |
| Other |
heart failure self-care education |
1 |
2009 |
| Behavioral |
heart failure self-management education |
1 |
2016 |
| Behavioral |
heart failure self care support |
1 |
2010 |
| Other |
heart failure usual care |
1 |
2013 |
| Behavioral |
heart pact program |
1 |
2005 |
| Device |
heart rate setting |
1 |
2006 |
| Other |
heart rehabilitation |
1 |
2016 |
| Behavioral |
heart self care tracker |
1 |
2009 |
| Device |
heartlogic off |
1 |
2017 |
| Device |
heartlogic on |
1 |
2017 |
| Device |
heartman system |
1 |
2018 |
| Other |
heartmapp |
1 |
2019 |
| Other |
heartmapp/ct |
1 |
2019 |
| Device |
heartmate 3 |
1 |
2010 |
| Device |
heartmate ii |
1 |
2012 |
| Device |
heartmate ii (hmii) |
1 |
2016 |
| Device |
heartmate ii lvas |
1 |
2014 |
| Device |
heartware hvad |
1 |
2014 |
| Device |
heartware mvadâ® system |
1 |
2013 |
| Device |
heartwareâ® vas (hvad) |
1 |
2013 |
| Other |
hed pet |
1 |
2014 |
| Device |
hemodynamic group |
1 |
2014 |
| Behavioral |
hf dm self care |
1 |
2012 |
| Device |
hf pressure measurement system |
1 |
2007 |
| Other |
hf training |
1 |
2010 |
| Drug |
hf treatment according to swedish guidelines |
1 |
2006 |
| Drug |
high-dose loop diuretics |
1 |
2013 |
| Other |
high-intensity imt / aerobic/resistance exercise |
1 |
2017 |
| Behavioral |
high-intensity imt/walking |
1 |
2012 |
| Behavioral |
high-tech |
1 |
2018 |
| Behavioral |
high-touch |
1 |
2018 |
| Drug |
high dose bisoprolol |
1 |
2010 |
| Biological |
high dose trivalent influenza vaccine |
1 |
2016 |
| Drug |
high epa |
1 |
2014 |
| Other |
high fat |
1 |
2014 |
| Other |
high fat/low carbohydrate diet |
1 |
2014 |
| Device |
high flow nasal oxygen |
1 |
2018 |
| Other |
high intensity care |
1 |
2018 |
| Behavioral |
high intensity exercise |
1 |
2014 |
| Behavioral |
high intensity exercise training |
1 |
2005 |
| Other |
high intensity interval training (hiit) |
1 |
2013 |
| Other |
high potassium diet |
1 |
2017 |
| Other |
high spo2 |
1 |
2015 |
| Other |
his-ventricular (hv) optimisation |
1 |
2016 |
| Behavioral |
hitcm |
1 |
2007 |
| Behavioral |
hitcm only |
1 |
2007 |
| Behavioral |
hitcm/cp |
1 |
2007 |
| Device |
hm iii |
1 |
2015 |
| Behavioral |
home-based cardiac rehabilitation |
1 |
2016 |
| Other |
home-based disease management |
1 |
2011 |
| Other |
home-based exercise |
1 |
2010 |
| Procedure |
home-based hospitalization |
1 |
2017 |
| Other |
home-based telerehabilitation |
1 |
2015 |
| Device |
home-based tool |
1 |
2018 |
| Procedure |
home care telemedicine |
1 |
2005 |
| Other |
home exercise |
1 |
2014 |
| Other |
home hospitalization |
1 |
2016 |
| Device |
home monitoring |
1 |
2015 |
| Device |
home telemonitoring |
1 |
2018 |
| Procedure |
home telemonitoring of patients with chf |
1 |
2012 |
| Device |
home telemonitoring system |
1 |
2020 |
| Other |
home telemonitoring system (hts) |
1 |
2019 |
| Radiation |
home x-rays |
1 |
2010 |
| Behavioral |
homewalking exercise program |
1 |
2001 |
| Behavioral |
homing in on health |
1 |
2005 |
| Device |
hommed telemonitoring system |
1 |
2006 |
| Device |
honeywell hommed telemonitor |
1 |
2011 |
| Drug |
hormone replacement therapy |
1 |
2002 |
| Other |
hospital-community-family-care management platform online |
1 |
2013 |
| Biological |
hpsc-cm therapy |
1 |
2018 |
| Procedure |
human cardiac stem cells |
1 |
2009 |
| Biological |
human embryonic stem cell-derived cd15 |
1 |
2013 |
| Biological |
human embryonic stem cell-derived cd15/ isl-1/ progenitors |
1 |
2013 |
| Drug |
human recombinant growth hormone |
1 |
2005 |
| Dietary Supplement |
hvmn ketone ester |
1 |
2020 |
| Drug |
hydralazine isosorbide dinitrate |
1 |
2018 |
| Drug |
hydralazine/amlodipine |
1 |
2010 |
| Dietary Supplement |
hypercaloric beverages |
1 |
2015 |
| Drug |
hypermellose (tablet a) |
1 |
2016 |
| Drug |
hypermellose (tablet b) |
1 |
2016 |
| Drug |
hypermellose (tablet c) |
1 |
2016 |
| Drug |
hypertonic saline solution |
1 |
2009 |
| Other |
hyperventilation test |
1 |
2018 |
| Other |
hypoxia air |
1 |
2018 |
| Drug |
i-123-mibg |
1 |
2015 |
| Device |
î¼cor |
1 |
2019 |
| Device |
iasd |
1 |
2013 |
| Device |
iasd implant |
1 |
2017 |
| Device |
iasd system |
1 |
2012 |
| Device |
iasd system ii implant |
1 |
2017 |
| Drug |
icatibant |
1 |
2019 |
| Behavioral |
icd decision aid toolkit |
1 |
2013 |
| Device |
icd/crt-d |
1 |
2010 |
| Device |
icd/crt-d with home monitoring feature activated |
1 |
2007 |
| Device |
icd/crt-d with home monitoring feature deactivated |
1 |
2007 |
| Device |
icd/crt implant |
1 |
2008 |
| Behavioral |
icdm |
1 |
2011 |
| Drug |
iepo |
1 |
2017 |
| Device |
ihm in combination with single chamber icd (chronicle icd) |
1 |
2006 |
| Device |
ik-5001 |
1 |
2010 |
| Behavioral |
illness management |
1 |
2011 |
| Behavioral |
illness management only |
1 |
2011 |
| Drug |
iloprost |
1 |
2018 |
| Other |
image fusion of spect mpi |
1 |
2017 |
| Other |
image fusion of spect mpi/fluoroscopy venography |
1 |
2017 |
| Procedure |
image guided cardiac resynchronization therapy (crt) device lead placement. |
1 |
2011 |
| Other |
imaging guided lv lead positioning |
1 |
2011 |
| Other |
imaging guided optimal lv lead placement |
1 |
2011 |
| Device |
impedance measurement system |
1 |
2017 |
| Device |
impedance monitoring feature |
1 |
2009 |
| Device |
implant of investigational device system |
1 |
2011 |
| Device |
implant of pressure sensor. |
1 |
2008 |
| Device |
implant of the hw005 ventricular assist system. |
1 |
2014 |
| Device |
implant of the invicta lead |
1 |
2018 |
| Device |
implantable cardiac resynchronisation (pacing) device |
1 |
2005 |
| Device |
implantable cardioverter defibrillator (icd) |
1 |
2005 |
| Device |
implantable cardioverter defibrillator (icd) with crt |
1 |
2005 |
| Device |
implantable defibrillator (icd) |
1 |
2005 |
| Device |
implantable device: monitoring of intrathoracic impedance using the optivol diagnostic tool. |
1 |
2005 |
| Device |
implantable hemodynamic monitor (chronicleâ® ihm), |
1 |
2006 |
| Device |
implantable hemodynamic monitor (chronicleâ® ihm),/ihm in combination with single chamber icd (chronicle icd) |
1 |
2006 |
| Device |
implantable pulse generators |
1 |
2006 |
| Procedure |
implantation |
1 |
2007 |
| Device |
implantation of a cardiac resynchronisation therapy (crt) pacing device with |
1 |
2017 |
| Device |
implantation of a cardiac resynchronisation therapy (crt) pacing device with/without implanted cardioverter defibrillator |
1 |
2017 |
| Procedure |
implantation of a his-pacing lead |
1 |
2018 |
| Procedure |
implantation of a lv-pacing lead |
1 |
2018 |
| Device |
implantation of the v-wave inter-atrial shunt |
1 |
2013 |
| Procedure |
implantation/activation of the vagus nerve stimulator |
1 |
2007 |
| Other |
improved primary care hf diagnostics |
1 |
2020 |
| Other |
imt |
1 |
2015 |
| Other |
in-clinic check-ups |
1 |
2012 |
| Other |
in-person primary care clinical follow-up visit |
1 |
2018 |
| Procedure |
inactive cross over |
1 |
2012 |
| Drug |
increased intravenous bolus loop diuretic dose (bumetanide |
1 |
2015 |
| Drug |
increased intravenous bolus loop diuretic dose (bumetanide/furosemide) |
1 |
2015 |
| Behavioral |
increasing daily unsaturated fatty acid consumption |
1 |
2017 |
| Device |
incremental pump speed of cf-lvad. |
1 |
2012 |
| Drug |
incretin effect |
1 |
2017 |
| Drug |
indacaterol |
1 |
2015 |
| Drug |
indacaterol fumarate |
1 |
2013 |
| Behavioral |
independent walking |
1 |
2010 |
| Other |
index group |
1 |
2010 |
| Biological |
influenza vaccine |
1 |
2014 |
| Biological |
influenza virus vaccine (influvac |
1 |
2009 |
| Biological |
influenza virus vaccine (influvac/vaxigrip) |
1 |
2009 |
| Behavioral |
informed assent discussion |
1 |
2016 |
| Biological |
infusion of 3-ohb |
1 |
2017 |
| Drug |
infusion of autologous mononuclear bone marrow cells |
1 |
2014 |
| placebo |
infusion of placebo |
1 |
2017 |
| Drug |
inhaled nebulized milrinone |
1 |
2014 |
| Drug |
inhaled nitrite |
1 |
2011 |
| Other |
initial evaluation |
1 |
2014 |
| Biological |
injection of c3bs-cqr-1 |
1 |
2012 |
| Procedure |
injection procedures. |
1 |
2008 |
| Drug |
inl1 |
1 |
2019 |
| Other |
innovative supported |
1 |
2018 |
| Drug |
ino |
1 |
2017 |
| Other |
inpatient hospitalization |
1 |
2016 |
| Device |
inspiratory muscle endurance training |
1 |
2018 |
| Other |
inspiratory muscle exercise |
1 |
2011 |
| Device |
inspiratory muscle strength training |
1 |
2018 |
| Behavioral |
inspiratory muscle training exercise intervention |
1 |
2018 |
| Other |
inspiratory training |
1 |
2018 |
| Drug |
inspra (eplerenone) |
1 |
2013 |
| Behavioral |
instruction |
1 |
2008 |
| Drug |
insulin glargine |
1 |
2008 |
| Other |
integrated cardiac rehabilitation |
1 |
2018 |
| Other |
integrated care |
1 |
2011 |
| Other |
integrated diagnositic system |
1 |
2010 |
| Other |
integrated disease management |
1 |
2019 |
| Behavioral |
integration of a team based clinical pharmacist |
1 |
2006 |
| Device |
intel health guide |
1 |
2010 |
| Behavioral |
intensive quality improvement tools |
1 |
2009 |
| Device |
inter-atrial shunt device |
1 |
2015 |
| Other |
interactive platform with telemonitoring. |
1 |
2012 |
| Behavioral |
interactive voice response system |
1 |
2007 |
| Behavioral |
interdisciplinary educational program |
1 |
2019 |
| Behavioral |
interdisciplinary palliative care |
1 |
2012 |
| Device |
intermittent sequntial pnumatic compression leg sleeves |
1 |
2012 |
| Device |
internal electrocardioversion |
1 |
2014 |
| Behavioral |
interpersonal |
1 |
2006 |
| Behavioral |
interpersonal/behavioral psychotherapy |
1 |
2006 |
| Other |
interruption of antibiotic treatment due to pct measurement |
1 |
2016 |
| Other |
interval exercise training |
1 |
2013 |
| Other |
intervention care |
1 |
2009 |
| Behavioral |
intervention group |
1 |
2017 |
| Device |
intervention using mhealth |
1 |
2015 |
| Other |
interventions with heart failure medications |
1 |
2011 |
| Device |
interventricular pacing delay optimization by using tissue doppler-derived displacement curves |
1 |
2010 |
| Other |
intra-cardiac echocardiography (ice), |
1 |
2017 |
| Other |
intra-cardiac echocardiography (ice),/transesophageal echocardiography (tee) |
1 |
2017 |
| Other |
intracardiac echo |
1 |
2015 |
| Device |
intracardiac impedance measurement algorithm (integrated in crt-d device) |
1 |
2012 |
| Biological |
intracoronary administration of the umbilical cord-derived mesenchymal stromal cells |
1 |
2020 |
| Biological |
intracoronary infusion of autologous bone marrow-derived cells |
1 |
2012 |
| Procedure |
intracoronary infusion of bmc |
1 |
2006 |
| Procedure |
intracoronary injection |
1 |
2011 |
| Procedure |
intracoronary stem cell therapy |
1 |
2006 |
| Biological |
intramyocardial delivery of bone marrow derived mononuclear cells |
1 |
2009 |
| Procedure |
intramyocardial injection |
1 |
2011 |
| Procedure |
intramyocardial injection of autologous cd133 |
1 |
2007 |
| Procedure |
intramyocardial injection of autologous cd133/ marrow cells |
1 |
2007 |
| Drug |
intrathecal fentanyl |
1 |
2014 |
| Device |
intrathoracic impedance measurement |
1 |
2008 |
| Device |
intravascular ventricular assist system (ivas) |
1 |
2015 |
| Drug |
intravenous furosemide |
1 |
2015 |
| Drug |
intravenous loop diuretic |
1 |
2017 |
| Diagnostic Test |
invasive catheter-based mapping |
1 |
2020 |
| Device |
invasive mapping with carto3 system |
1 |
2011 |
| Device |
invasive mapping with carto3 system/non-invasive mapping with cardioinsight atlas ec mapping system |
1 |
2011 |
| Device |
investigational linqâ„¢ hf ramware |
1 |
2018 |
| Biological |
inxn-4001 |
1 |
2017 |
| Drug |
iohexol |
1 |
2019 |
| Drug |
iron |
1 |
2016 |
| Drug |
iron oligosaccharide |
1 |
2007 |
| Drug |
iron sucrose |
1 |
2015 |
| Drug |
iron sucrose iv |
1 |
2019 |
| Other |
ischemic cold static storage |
1 |
2017 |
| Procedure |
ischemic exercise training |
1 |
2006 |
| Biological |
isl-1 |
1 |
2013 |
| Diagnostic Test |
isokinetic dynamometer |
1 |
2020 |
| Drug |
isoproterenol |
1 |
2015 |
| Drug |
isosorbide dinitrate |
1 |
2012 |
| Drug |
isosorbide dinitrate / hydralazine |
1 |
2012 |
| Drug |
isosorbide mononitrate |
1 |
2014 |
| Drug |
isotonic saline infusion |
1 |
2006 |
| Drug |
istaroxime |
1 |
2008 |
| Drug |
iti-214 |
1 |
2017 |
| Drug |
itraconazole |
1 |
2019 |
| Drug |
iv chlorothiazide |
1 |
2015 |
| Drug |
iv diuretic |
1 |
2005 |
| Drug |
iv diuretics |
1 |
2016 |
| Drug |
iv loop diuretic |
1 |
2006 |
| Drug |
ivabradine 5 mg [corlanor] |
1 |
2019 |
| Behavioral |
ivr |
1 |
2013 |
| Behavioral |
ivr-enhanced care |
1 |
2010 |
| Drug |
iw-1973 |
1 |
2017 |
| Device |
jarvik 2000 vas |
1 |
2012 |
| Drug |
jnj-39588146 15 ng |
1 |
2010 |
| Drug |
jnj-39588146 15 ng/kg/min |
1 |
2010 |
| Drug |
jnj-39588146 30 ng |
1 |
2010 |
| Drug |
jnj-39588146 30 ng/kg/min |
1 |
2010 |
| Drug |
jnj-39588146 5 ng |
1 |
2010 |
| Drug |
jnj-39588146 5 ng/kg/min |
1 |
2010 |
| Drug |
jnj-39588146 5, 15, |
1 |
2010 |
| Drug |
jnj-39588146 5, 15,/30 ng/kg/min |
1 |
2010 |
| Behavioral |
jumpstart intervention |
1 |
2018 |
| Behavioral |
justification nudge |
1 |
2018 |
| Device |
kaneka liposorber |
1 |
2007 |
| Other |
karate rehabilitation |
1 |
2019 |
| Drug |
kcentra |
1 |
2017 |
| Drug |
kcl |
1 |
2014 |
| Drug |
kg |
1 |
2010 |
| Device |
kinesio tape |
1 |
2018 |
| Drug |
kno3 |
1 |
2014 |
| Drug |
kno3, potassium nitrate |
1 |
2016 |
| Device |
kronos lv-t, lumax hf-t |
1 |
2006 |
| Drug |
kuvan |
1 |
2014 |
| Device |
kyma device u-cor system |
1 |
2014 |
| Drug |
lactated |
1 |
2015 |
| placebo |
lcz696 placebo |
1 |
2016 |
| Drug |
ldv fdc) |
1 |
2016 |
| Other |
lecg first |
1 |
2011 |
| Drug |
ledipasvir fixed dose combination(sof |
1 |
2016 |
| Device |
left atrial pressure monitoring system |
1 |
2010 |
| Procedure |
left cervico-thoracic sympathetic blockade |
1 |
2010 |
| Device |
left ventricular assist device |
1 |
1999 |
| Device |
left ventricular assist device (heartmate ii) |
1 |
2009 |
| Device |
left ventricular assist device (lvad) |
1 |
2015 |
| Device |
left ventricular capture management software |
1 |
2005 |
| Other |
leg rising |
1 |
2013 |
| Device |
less invasive mitral valve repair |
1 |
2005 |
| Other |
level 1: (provide site-specifi information) |
1 |
2009 |
| Other |
level 2 (provide site- |
1 |
2009 |
| Other |
level 2 (provide site-/patient-specific information) |
1 |
2009 |
| Drug |
levocarnitine injection |
1 |
2012 |
| placebo |
levocarnitine placebo |
1 |
2012 |
| Drug |
levosimendan 2.5 mg/ml |
1 |
2017 |
| Drug |
levosimendan 2.5 mg/ml injectable solution |
1 |
2018 |
| Other |
li-guided therapy |
1 |
2016 |
| Other |
life completion/preparation |
1 |
2008 |
| Other |
life extension default ad forms |
1 |
2013 |
| Device |
lifepod |
1 |
2020 |
| Behavioral |
lifestyle counseling |
1 |
2010 |
| Dietary Supplement |
lifestyle modification |
1 |
2015 |
| Behavioral |
lifestyle modification (diet, exercise, |
1 |
2006 |
| Behavioral |
lifestyle modification (diet, exercise,/behavior) |
1 |
2006 |
| Device |
lifestyle monitoring system |
1 |
2005 |
| Device |
lifevest |
1 |
2016 |
| Other |
light weights |
1 |
2014 |
| Drug |
lisinopril |
1 |
2006 |
| Drug |
lixivaptan |
1 |
2010 |
| Drug |
lmi 1195-101 |
1 |
2009 |
| Drug |
lmwh |
1 |
2018 |
| Other |
local strengthening exercises |
1 |
2016 |
| Drug |
loop diuretic |
1 |
2013 |
| Drug |
losartan 150 mg |
1 |
2004 |
| Drug |
losartan 50 mg |
1 |
2004 |
| Drug |
low-dose loop diuretics |
1 |
2013 |
| Other |
low-epicatechin dark chocolate |
1 |
2012 |
| Other |
low-intensity group |
1 |
2014 |
| Other |
low-intensity imt / aerobic/resistance exercise |
1 |
2017 |
| Behavioral |
low-intensity imt/walking |
1 |
2012 |
| Device |
low-level laser therapy |
1 |
2020 |
| Other |
low-sodium diet (1500 mg daily) |
1 |
2011 |
| Other |
low carbohydrate diet |
1 |
2014 |
| Drug |
low dose bisoprolol |
1 |
2010 |
| Device |
low electrical myostimulation |
1 |
2011 |
| Other |
low intensity exercise |
1 |
2010 |
| Other |
low spo2 |
1 |
2015 |
| Other |
lung |
1 |
2015 |
| Diagnostic Test |
lung function test |
1 |
2020 |
| Device |
lung impedance-guided therapy |
1 |
2012 |
| Other |
lung/subcutaneous ultrasound |
1 |
2015 |
| Other |
lus-guided strategy-of-care |
1 |
2017 |
| Combination Product |
lus-guided therapy |
1 |
2018 |
| Procedure |
lv dp |
1 |
2009 |
| Procedure |
lv dp/dt pressure measurement |
1 |
2009 |
| Device |
lv endocardial crt |
1 |
2016 |
| Device |
lv lead (quartetâ„¢ lead |
1 |
2009 |
| Other |
lv lead placement as per standard of care (without echo guidance) |
1 |
2005 |
| Other |
lv stimulus intensity |
1 |
2010 |
| Other |
lvad decision aid |
1 |
2014 |
| Dietary Supplement |
lycopene supplements |
1 |
2012 |
| Drug |
macitentan |
1 |
2017 |
| Drug |
macitentan 10 mg |
1 |
2018 |
| Drug |
magnesium oxide |
1 |
2019 |
| Device |
magnetic nerve stimulators |
1 |
2014 |
| Other |
magnetic resonance imaging |
1 |
2015 |
| Dietary Supplement |
maltodextrin |
1 |
2020 |
| Behavioral |
management app |
1 |
2017 |
| Procedure |
mapping |
1 |
2019 |
| Procedure |
mapping/pacing the his bundle |
1 |
2019 |
| Procedure |
marrow cells |
1 |
2007 |
| placebo |
matched placebo (capsules) |
1 |
2007 |
| placebo |
matching placebo |
1 |
2018 |
| placebo |
matching placebo enalapril |
1 |
2016 |
| placebo |
matching placebo patch |
1 |
2009 |
| placebo |
matching placebo sacubitril |
1 |
2016 |
| Drug |
matching placebo sacubitril/valsartan (lcz696) |
1 |
2016 |
| Behavioral |
mawds data entry on app |
1 |
2017 |
| Diagnostic Test |
maximal functional capacity by cardiopulmonary exercise testing |
1 |
2019 |
| Behavioral |
mayoexpertadvisor |
1 |
2016 |
| Drug |
mcc-135 |
1 |
2002 |
| Behavioral |
mct |
1 |
2016 |
| Procedure |
measure of left ventricular |
1 |
2012 |
| Procedure |
measure of left ventricular/diastolic pressure at exercise |
1 |
2012 |
| Drug |
mecasermin |
1 |
2011 |
| Other |
mechanical ventilation video. |
1 |
2013 |
| Procedure |
med |
1 |
2001 |
| Other |
medical evaluation |
1 |
2018 |
| Diagnostic Test |
medical imaging |
1 |
2019 |
| Other |
medical management of tricuspid regurgitation |
1 |
2018 |
| Drug |
medical therapy |
1 |
2019 |
| Drug |
medical ventricular rate control |
1 |
2012 |
| Behavioral |
medication adherence telemonitoring |
1 |
2015 |
| Other |
medication education tool |
1 |
2006 |
| Drug |
medication management |
1 |
2018 |
| Drug |
medication suspension (dms) |
1 |
2017 |
| Drug |
medication to control ventricular rate in af |
1 |
2009 |
| Device |
mediguideâ„¢ |
1 |
2012 |
| Behavioral |
meds to beds |
1 |
2018 |
| Device |
medtronic 4196 lead |
1 |
2018 |
| Device |
medtronic icd with opti vol-monitor |
1 |
2019 |
| Device |
medtronic primeadvanced neurostimulator |
1 |
2010 |
| Drug |
melatonin 10 mg |
1 |
2019 |
| Behavioral |
memory training |
1 |
2016 |
| Biological |
mesenchymal precursor cells (mpcs) |
1 |
2008 |
| Biological |
mesenchymal stem cell transplantation |
1 |
2015 |
| Biological |
mesenchymal stem cells (msc) |
1 |
2015 |
| Biological |
mesenchymal stromal cell |
1 |
2008 |
| Other |
metabolic substrate modulation |
1 |
2010 |
| Drug |
metformini hydrochloridum (siofor 1000 tbl, berlin) |
1 |
2012 |
| Other |
methodology |
1 |
2017 |
| Drug |
methotrexate |
1 |
2008 |
| Drug |
methylprednisolone |
1 |
2017 |
| Drug |
metolazone 5 mg |
1 |
2016 |
| Drug |
metolazone 5 mg / iv diuretics |
1 |
2016 |
| Drug |
metolazone oral tablet |
1 |
2018 |
| Drug |
metoprolol xr |
1 |
2019 |
| Behavioral |
mi |
1 |
2013 |
| Behavioral |
mi-based educational control condition |
1 |
2017 |
| Behavioral |
mi / ivr |
1 |
2013 |
| Genetic |
microarray analysis |
1 |
2011 |
| Drug |
micronutrients |
1 |
2011 |
| Drug |
midazolam |
1 |
2013 |
| Drug |
milrinone |
1 |
2013 |
| Drug |
milrinone 10mg er |
1 |
2013 |
| Drug |
milrinone 14mg |
1 |
2013 |
| Drug |
milrinone 6mg |
1 |
2013 |
| Drug |
min |
1 |
2010 |
| Behavioral |
mindful steps |
1 |
2016 |
| Behavioral |
mindfulness training (mt) |
1 |
2018 |
| Device |
minimal extracorporeal circulation (mec) |
1 |
2016 |
| Behavioral |
minnesota living heart failure questionnaire (mlhf) |
1 |
2014 |
| Device |
mio slice |
1 |
2019 |
| Drug |
mirabegron |
1 |
2017 |
| Dietary Supplement |
mitoq |
1 |
2019 |
| Device |
mitraclip |
1 |
2019 |
| Device |
mitraclip system |
1 |
2012 |
| Device |
mitral valve repair |
1 |
2017 |
| Drug |
ml inj 15ml |
1 |
2017 |
| Drug |
ml injectable solution |
1 |
2018 |
| Other |
mobile health technology platform |
1 |
2019 |
| Device |
mobile phone app (vad care app) |
1 |
2017 |
| Procedure |
mobile team |
1 |
2007 |
| Other |
moderate-intensity group |
1 |
2014 |
| Behavioral |
moderate continuous exercise |
1 |
2014 |
| Other |
moderate intensity continuous exercise training |
1 |
2013 |
| Behavioral |
moderate intensity continuous training |
1 |
2017 |
| Other |
monthly review arm |
1 |
2009 |
| Behavioral |
motivational interviewing tailored intervention |
1 |
2014 |
| Behavioral |
motivational support only |
1 |
2013 |
| Drug |
moxifloxacin |
1 |
2018 |
| Drug |
moxifloxacin 400 mg |
1 |
2018 |
| Device |
mpp |
1 |
2013 |
| Device |
mpp on |
1 |
2015 |
| Drug |
mtp-131 |
1 |
2015 |
| Behavioral |
multi-domain rehabilitation intervention |
1 |
2014 |
| Other |
multi-professional breathlessness service (mbs) |
1 |
2015 |
| Other |
multicomponent treatment |
1 |
2005 |
| Behavioral |
multidisciplinary palliative care team met with patient |
1 |
2006 |
| Other |
multifaceted strategy based on sending text messages(sms) |
1 |
2019 |
| Other |
multilevel guided discharge planning |
1 |
2018 |
| Device |
multipoint pacing |
1 |
2013 |
| Device |
multipole pacing |
1 |
2017 |
| Device |
multispot sequential lv-ventricular pacing (multispot-seq) |
1 |
2016 |
| Device |
multispot simultaneous lv-ventricular pacing (multispot-syn) |
1 |
2016 |
| Drug |
muscle contraction with metabolite solution administration |
1 |
2013 |
| Genetic |
mydicar phase 1 (open-label, serial dose-escalation study) |
1 |
2007 |
| placebo |
mydicar phase 2 (placebo-controlled, randomized study) |
1 |
2007 |
| Other |
myia healthâ® remote patient monitoring unblinded treatment arm |
1 |
2020 |
| Drug |
myk-491 |
1 |
2018 |
| Other |
myocardial perfusion scintigraphy |
1 |
2015 |
| Radiation |
myocardial scintigraphy |
1 |
2015 |
| Drug |
n-3 pufa |
1 |
2006 |
| Drug |
n-3 pufas |
1 |
2010 |
| Drug |
nacl 0,9% |
1 |
2007 |
| Drug |
nacl 7,5% (hypertonic saline solution) |
1 |
2007 |
| Behavioral |
narrative intervention |
1 |
2019 |
| Drug |
natrecor (nesiritide) |
1 |
2005 |
| placebo |
natrecor, a recombinant form of b-type natriuretic peptide, made by scios, inc. vs. placebo |
1 |
2005 |
| Device |
navh |
1 |
2016 |
| Drug |
nebulized sodium nitrite |
1 |
2016 |
| Drug |
neprilysin |
1 |
2017 |
| Drug |
neseritide |
1 |
2006 |
| Drug |
nesiritide (1 |
1 |
2007 |
| Drug |
nesiritide (1/0.01) |
1 |
2007 |
| Drug |
nesiritide (2 |
1 |
2007 |
| Drug |
nesiritide (2/0.005) |
1 |
2007 |
| Drug |
nesiritide (natrecor(tm)) |
1 |
2005 |
| Drug |
nesiritide, furosemide |
1 |
2008 |
| Drug |
nesritide (2 |
1 |
2007 |
| Drug |
nesritide (2/0.01) |
1 |
2007 |
| Dietary Supplement |
nestlã© noir intense 40 grx2 |
1 |
2007 |
| placebo |
nestlã© placebo chocolate 40 grx2 |
1 |
2007 |
| Device |
neurally adjusted ventilatory assist (nava) provided by a commercially available mechanical ventilator (servo i, maquet critical care, solna, sweden). |
1 |
2008 |
| Drug |
neuregulin 1î²3 |
1 |
2010 |
| Device |
neuromuscular electrical stimulation (nmes) |
1 |
2018 |
| Device |
neuromuscular electrical stimulator |
1 |
2016 |
| Device |
neurotronik cans therapy system |
1 |
2016 |
| Device |
neurotronik cans therapyâ„¢ system |
1 |
2017 |
| Device |
neurotronik cans therapyâ® system |
1 |
2018 |
| Device |
new living chf |
1 |
2008 |
| Procedure |
new model of ambulatory care with use of of non-invasive vital signs assessment |
1 |
2018 |
| Procedure |
new model of ambulatory care with use of of non-invasive vital signs assessment/telemedicine |
1 |
2018 |
| Diagnostic Test |
new york heart association class i |
1 |
2018 |
| Diagnostic Test |
new york heart association class ii-iv |
1 |
2018 |
| Drug |
ng-monomethyl-l-arginine (drug) |
1 |
2006 |
| Other |
nhgdoc domain heart failure |
1 |
2012 |
| Other |
nicas guided crt optimization |
1 |
2014 |
| Device |
nicas system |
1 |
2013 |
| Drug |
nicorandil |
1 |
2009 |
| Device |
nintendo wii fit |
1 |
2019 |
| Dietary Supplement |
nitrate-free beetroot juice |
1 |
2018 |
| Dietary Supplement |
nitrate depleted beetroot juice |
1 |
2013 |
| Dietary Supplement |
nitrate rich beetroot juice |
1 |
2013 |
| Dietary Supplement |
nitrate supplementation |
1 |
2015 |
| Drug |
nitrates |
1 |
2017 |
| Drug |
nitrite |
1 |
2013 |
| Drug |
nitrogen |
1 |
2003 |
| Drug |
nitroglycerin (ntg) |
1 |
2017 |
| Other |
no-crt |
1 |
2011 |
| Other |
no additional treatment |
1 |
2007 |
| Other |
no hf training |
1 |
2010 |
| Device |
no home monitoring |
1 |
2015 |
| Behavioral |
no intervention–usual care |
1 |
2017 |
| Other |
no intervention: optimal medical therapy |
1 |
2011 |
| Behavioral |
no intervervention usual care |
1 |
2017 |
| Device |
nocturnal oxygen |
1 |
2010 |
| Device |
nocturnal oxygen treatment from oxygen concentrators |
1 |
2006 |
| Device |
nocturnal supplemental oxygen |
1 |
2013 |
| Drug |
non-arb |
1 |
2005 |
| Diagnostic Test |
non-invasive body surface mapping |
1 |
2020 |
| Other |
non-invasive haemodynamic optimisation |
1 |
2010 |
| Device |
non-invasive mapping with cardioinsight atlas ec mapping system |
1 |
2011 |
| Device |
non-invasive ventilation |
1 |
2018 |
| Other |
non-ischemic preservation |
1 |
2017 |
| Device |
non invasive ventilation (niv) |
1 |
2017 |
| Procedure |
noninvasive electrical dyssynchrony study |
1 |
2017 |
| Device |
noninvasive ventilation (bi-pap) |
1 |
2017 |
| Device |
noninvasive ventilation (cpap) |
1 |
2017 |
| Other |
noninvasive ventilatory support |
1 |
2015 |
| Behavioral |
nordic walking |
1 |
2014 |
| Diagnostic Test |
norepinephrine |
1 |
2018 |
| Other |
normal rv pacing |
1 |
2005 |
| Drug |
normal saline (0.9%) |
1 |
2007 |
| Other |
normal saline 0.9% |
1 |
2016 |
| Other |
notices |
1 |
2009 |
| Diagnostic Test |
nt-pro bnp |
1 |
2018 |
| Other |
nt-probnp (cardiac biomarkers) |
1 |
2016 |
| Other |
nt-probnp guided discharge |
1 |
2011 |
| Other |
nt-probnp guided hf therapy |
1 |
2006 |
| Device |
nt-probnp measurements |
1 |
2005 |
| Procedure |
nt-probnp testing |
1 |
2006 |
| Other |
nurse-based care |
1 |
2017 |
| Behavioral |
nurse-led group clinic visits |
1 |
2007 |
| Behavioral |
nurse-management |
1 |
2005 |
| Drug |
nurse management |
1 |
2006 |
| Procedure |
nurse monitored heart failure program |
1 |
2012 |
| Dietary Supplement |
nutridrink |
1 |
2008 |
| Other |
nutrition education |
1 |
2019 |
| Other |
nutritional |
1 |
2020 |
| Behavioral |
nutritional education |
1 |
2009 |
| Dietary Supplement |
nutritional supplementation |
1 |
2020 |
| Dietary Supplement |
nutritional supplementation/pulmonary rehabilitation |
1 |
2020 |
| Other |
nutritional support |
1 |
2018 |
| Other |
nutritional/dietary manipulation |
1 |
2020 |
| Device |
nxstage system one |
1 |
2006 |
| Diagnostic Test |
nyha assessment |
1 |
2019 |
| Device |
occlutech afr device |
1 |
2017 |
| Behavioral |
older drivers website |
1 |
2019 |
| Drug |
olmesartan medoxomil |
1 |
2006 |
| Dietary Supplement |
omacor |
1 |
2005 |
| Dietary Supplement |
omega 3 |
1 |
2012 |
| Dietary Supplement |
omega 3/lycopene supplements |
1 |
2012 |
| Dietary Supplement |
omga3 |
1 |
2010 |
| Other |
omm, optimal medical management |
1 |
2015 |
| Other |
on-demand audio messages of heart failure education themes |
1 |
2016 |
| Drug |
opc-41061 (tolvaptan) |
1 |
2007 |
| Drug |
opc-61815 |
1 |
2018 |
| Drug |
opc-61815 16mg |
1 |
2018 |
| Drug |
opc-61815 32mg |
1 |
2018 |
| Drug |
opc-61815 injection 16 mg |
1 |
2019 |
| Drug |
opc-61815 injection 16mg |
1 |
2017 |
| Drug |
opc-61815 injection 2mg |
1 |
2017 |
| Drug |
opc-61815 injection 4mg |
1 |
2017 |
| Drug |
opc-61815 injection 8 mg |
1 |
2019 |
| Drug |
opc-61815 injection 8mg |
1 |
2017 |
| Behavioral |
opinion leader generated |
1 |
2005 |
| Behavioral |
opinion leader generated/endorsed evidence summaries |
1 |
2005 |
| Other |
opt out approach for ahcah liaison visit |
1 |
2018 |
| Device |
optilogg |
1 |
2018 |
| Behavioral |
optimal discharge planning |
1 |
2018 |
| Biological |
optimal heart failure therapy |
1 |
2016 |
| Other |
optimal medical treatment |
1 |
2007 |
| Other |
optimisation of v-v timing using r wave on surface ecg |
1 |
2014 |
| Device |
optimisation of vv delay |
1 |
2010 |
| Other |
optimised heart failure management |
1 |
2013 |
| Diagnostic Test |
optimization of crt device |
1 |
2017 |
| Device |
optimization using echocardiography |
1 |
2010 |
| Other |
optimized echo-guided crt pacing |
1 |
2005 |
| Device |
optimized interventricular delay biventricular pacing |
1 |
2007 |
| Device |
optimizer smart |
1 |
2017 |
| Device |
optimizer smart system |
1 |
2017 |
| Device |
optimizer smart system with 2-leads |
1 |
2017 |
| Procedure |
optimizing myocardial lead placement for cardiac resynchronization therapy (crt) devices |
1 |
2011 |
| Behavioral |
optimizing processes of care |
1 |
2006 |
| Drug |
optimizing therapeutic treatments |
1 |
2006 |
| Other |
or crt |
1 |
2013 |
| Other |
or handout |
1 |
2017 |
| Dietary Supplement |
oral 3-hydroxybutyrate salts |
1 |
2019 |
| Drug |
oral furosemide tablets (80 mg) |
1 |
2014 |
| Drug |
oral myeloperoxidase inhibitor |
1 |
2018 |
| Dietary Supplement |
oral nutrition supplement, food for special medical purposes |
1 |
2009 |
| Drug |
oral r,r’-fenoterol |
1 |
2011 |
| Drug |
oral racemic fenoterol |
1 |
2011 |
| Dietary Supplement |
oral sodium chloride |
1 |
2020 |
| Drug |
oral sodium nitrite |
1 |
2016 |
| Device |
organ care system |
1 |
2009 |
| Procedure |
organ perfusion for heart transplantation |
1 |
2015 |
| Procedure |
orthostatic test |
1 |
2015 |
| Procedure |
outpatient clinic follow-up |
1 |
2006 |
| Device |
oxycon mobile |
1 |
2019 |
| Procedure |
oxygen application |
1 |
2019 |
| Drug |
oxypurinol |
1 |
2003 |
| Device |
p-ecm implant |
1 |
2014 |
| Procedure |
pace make active |
1 |
2012 |
| Procedure |
pace make active/inactive cross over |
1 |
2012 |
| Device |
pacemaker medtronic enrhythm |
1 |
2005 |
| Device |
pacemaker system will be implanted but set to pacing off. |
1 |
2014 |
| Device |
pacemaker: av optimised, his pacing. |
1 |
2016 |
| Device |
pacing lead (model 4296 lv lead) |
1 |
2009 |
| Procedure |
pacing the his bundle |
1 |
2019 |
| Other |
pact-hf model |
1 |
2014 |
| Behavioral |
palliative care |
1 |
2011 |
| Other |
palliative care consultation |
1 |
2012 |
| Other |
palliative care intervention |
1 |
2014 |
| Procedure |
papillary muscle approximation |
1 |
2017 |
| Drug |
para-aminohippurate |
1 |
2019 |
| Device |
paradym crt |
1 |
2009 |
| Device |
paradym crt / physiological diagnosis (phd) |
1 |
2009 |
| Device |
paradym crt 8770 |
1 |
2014 |
| Device |
paradym rf sonr |
1 |
2011 |
| Other |
passive leg cycle exercise with stretching |
1 |
2008 |
| Other |
passive leg cycle exercise with stretching/resistance training |
1 |
2008 |
| Behavioral |
patch intervention |
1 |
2013 |
| Behavioral |
patient |
1 |
2005 |
| Behavioral |
patient-centered advance care planning |
1 |
2005 |
| Other |
patient-specific information) |
1 |
2009 |
| Device |
patient advisory module |
1 |
2010 |
| Behavioral |
patient engagement materials |
1 |
2017 |
| Behavioral |
patient heart failure mtm intervention |
1 |
2018 |
| Other |
patient navigator |
1 |
2012 |
| Behavioral |
patient/family education |
1 |
2005 |
| Drug |
pb1046 injection |
1 |
2016 |
| Drug |
pde-v |
1 |
2009 |
| Procedure |
peep decremental |
1 |
2015 |
| Procedure |
peep incremental |
1 |
2015 |
| Procedure |
percutaneous coronary intervention |
1 |
2013 |
| Procedure |
percutaneous intracoronary injection |
1 |
2008 |
| Procedure |
percutaneous intramyocardial injection |
1 |
2008 |
| Device |
percutaneous ventricular restoration using heartechâ® device |
1 |
2019 |
| Behavioral |
performance of wheels-i in promoting dash |
1 |
2017 |
| Behavioral |
performance of wheels-i in promoting dash/srd adoption |
1 |
2017 |
| Procedure |
pericardiotomy |
1 |
2019 |
| Other |
period of cardiac rehabilitation |
1 |
2014 |
| Drug |
peritoneal dialysis (pd) |
1 |
2012 |
| Behavioral |
person-centred care at distance |
1 |
2017 |
| Device |
personalised programming |
1 |
2018 |
| Device |
personalised rate-response settings |
1 |
2016 |
| Device |
pet scan |
1 |
1999 |
| Behavioral |
pharmaceutical counseling |
1 |
2015 |
| Other |
pharmacist discharge medication services |
1 |
2016 |
| Behavioral |
pharmacist heart failure mtm training |
1 |
2018 |
| Behavioral |
pharmacist intervention |
1 |
2006 |
| Other |
pharmacogenomic studies |
1 |
2011 |
| Other |
pharmacogenomic study |
1 |
2016 |
| Other |
pharmacological study |
1 |
2016 |
| Drug |
phenylephrine |
1 |
2007 |
| Drug |
phone contact |
1 |
2014 |
| Other |
phr messaging |
1 |
2016 |
| Procedure |
phrenic nerve stimulation |
1 |
2007 |
| Behavioral |
physical activity group |
1 |
2016 |
| Other |
physical therapy session |
1 |
2016 |
| Behavioral |
physical training |
1 |
2018 |
| Device |
physiological diagnosis (phd) |
1 |
2009 |
| Drug |
piboserod |
1 |
2007 |
| Drug |
pirfenidone |
1 |
2016 |
| Drug |
pitavastatin |
1 |
2008 |
| placebo |
placebo (10 mg) |
1 |
2014 |
| placebo |
placebo (dextrose) |
1 |
2012 |
| placebo |
placebo (for polysaccharide iron complex) |
1 |
2014 |
| placebo |
placebo (gummeline) |
1 |
2013 |
| placebo |
placebo (normal saline) |
1 |
2017 |
| placebo |
placebo (plasmalyte a) |
1 |
2015 |
| placebo |
placebo (saline) |
1 |
2011 |
| placebo |
placebo (treatment 1) |
1 |
2013 |
| placebo |
placebo (whey protein) |
1 |
2018 |
| placebo |
placebo bay 1753011 |
1 |
2019 |
| placebo |
placebo capsule |
1 |
2014 |
| placebo |
placebo capsules |
1 |
2017 |
| placebo |
placebo comparator: sugar pill |
1 |
2012 |
| placebo |
placebo electrical stimulation |
1 |
2013 |
| placebo |
placebo for aliskiren |
1 |
2010 |
| placebo |
placebo for allopurinol |
1 |
2020 |
| placebo |
placebo for cxl-1020 cohort 1 |
1 |
2010 |
| placebo |
placebo for cxl-1020 cohort 2 |
1 |
2010 |
| placebo |
placebo for vericiguat |
1 |
2016 |
| placebo |
placebo for verinurad |
1 |
2020 |
| placebo |
placebo furosemide |
1 |
2019 |
| placebo |
placebo group |
1 |
2014 |
| placebo |
placebo injection |
1 |
2016 |
| placebo |
placebo of lcz696 (sacubitril |
1 |
2016 |
| Drug |
placebo of lcz696 (sacubitril/valsartan) |
1 |
2016 |
| placebo |
placebo of tolvaptan |
1 |
2011 |
| placebo |
placebo of valsartan |
1 |
2016 |
| placebo |
placebo of vildagliptin |
1 |
2009 |
| placebo |
placebo phototherapy |
1 |
2017 |
| placebo |
placebo pills |
1 |
2017 |
| placebo |
placebo powder |
1 |
2017 |
| placebo |
placebo suspension |
1 |
2014 |
| placebo |
placebo tablet |
1 |
2010 |
| placebo |
placebo to aliskiren |
1 |
2009 |
| placebo |
placebo to empagliflozin |
1 |
2019 |
| placebo |
placebo to enalapril |
1 |
2015 |
| placebo |
placebo to lcz696 |
1 |
2015 |
| placebo |
placebo to match enalapril |
1 |
2017 |
| placebo |
placebo to match sacubitril |
1 |
2017 |
| Drug |
placebo to match sacubitril/valsartan |
1 |
2017 |
| placebo |
placebo to match saxagliptin |
1 |
2016 |
| placebo |
placebo to match sitagliptin |
1 |
2016 |
| placebo |
placebo to match valsartan |
1 |
2017 |
| placebo |
placebo to ramipril |
1 |
2009 |
| placebo |
placebo to sacubitril |
1 |
2017 |
| Drug |
placebo to sacubitril/valsartan |
1 |
2017 |
| placebo |
placebo to valsartan |
1 |
2017 |
| placebo |
placebo, |
1 |
2006 |
| Biological |
placebo/control arm |
1 |
2016 |
| Drug |
placebo/sugar pill |
1 |
2012 |
| Drug |
placebo/torasemide |
1 |
2015 |
| Procedure |
placing a guidewire in coronary sinus for measurement of q-lv during his bundle pacing or, if needed, for lv pacing |
1 |
2019 |
| Drug |
platelet inhibitors |
1 |
2000 |
| Other |
polygraphy |
1 |
2014 |
| Other |
polygraphy/ecg |
1 |
2014 |
| Genetic |
polymerase chain reaction |
1 |
2011 |
| Genetic |
polymorphism analysis |
1 |
2011 |
| Drug |
polysaccharide iron complex 150 mg |
1 |
2014 |
| Other |
pop up interruption alert |
1 |
2016 |
| Other |
positive psychology |
1 |
2011 |
| Other |
post-stroke rehabilitation program |
1 |
2015 |
| Drug |
potassium chloride (kcl) |
1 |
2016 |
| Drug |
potassium nitrate (kno3) |
1 |
2016 |
| Device |
powerbreathe (breathing muscle training) |
1 |
2019 |
| Behavioral |
prado-ic |
1 |
2017 |
| Drug |
prasugrel 10 mg daily x 2 weeks |
1 |
2012 |
| Drug |
pravastatin |
1 |
2008 |
| Procedure |
pre-discharge nt-probnp based treatment |
1 |
2007 |
| Other |
pre-procedure speckle-tracking echocardiography |
1 |
2013 |
| Device |
precardia system |
1 |
2019 |
| Device |
precision spinal cord stimulator system |
1 |
2016 |
| Other |
preoperative colloid fluid bolus (gelofusine) |
1 |
2018 |
| Diagnostic Test |
preoperative transthoracic echocardiography |
1 |
2018 |
| Other |
preparation/life completion |
1 |
2012 |
| Drug |
preset increase in frusemide dose |
1 |
2011 |
| Other |
preticard patient care management |
1 |
2016 |
| Procedure |
primary epicardial placement of left ventricular lead |
1 |
2011 |
| Behavioral |
primary palliative care |
1 |
2017 |
| Behavioral |
private feedback |
1 |
2018 |
| Drug |
probenecid 1 gr oral twice daily |
1 |
2013 |
| Dietary Supplement |
probiotic |
1 |
2018 |
| Behavioral |
problem-solving treatment |
1 |
2017 |
| Other |
problem solving therapy |
1 |
2019 |
| Biological |
progenitors |
1 |
2013 |
| Other |
programmer ecg first |
1 |
2011 |
| Other |
programming optimization by qrs |
1 |
2011 |
| Other |
progressive interval training |
1 |
2019 |
| Device |
promote qâ® device system) |
1 |
2009 |
| Other |
prompting |
1 |
2019 |
| Drug |
prostacyclin |
1 |
2012 |
| Other |
protocolized diuretic therapy |
1 |
2020 |
| Procedure |
provider education, computer reminders, nurse case management |
1 |
2001 |
| Behavioral |
psycho-behavioral intervention |
1 |
2017 |
| Behavioral |
psychoeducational |
1 |
2008 |
| Behavioral |
psychoeducational intervention by group (sg) |
1 |
2005 |
| Behavioral |
psychoeducational telephone counseling (tc) |
1 |
2005 |
| Behavioral |
psychospiritual |
1 |
2011 |
| Procedure |
ptca |
1 |
2000 |
| Procedure |
ptca/stents |
1 |
2000 |
| Other |
ptco2 |
1 |
2018 |
| Device |
ptma implant |
1 |
2007 |
| Behavioral |
publicly released hospital cardiac report cards |
1 |
2005 |
| Procedure |
pulmonary arterial denervation |
1 |
2014 |
| Dietary Supplement |
pulmonary rehabilitation |
1 |
2020 |
| Procedure |
pulse rate control |
1 |
2014 |
| Other |
pulse wave velocity |
1 |
2012 |
| Drug |
pyridostigmine bromide |
1 |
2011 |
| Drug |
qishenyiqi dropping pills |
1 |
2019 |
| Procedure |
qlv interval measurement |
1 |
2014 |
| Device |
quad group |
1 |
2011 |
| Device |
quadripolar lv lead (pacing configurations) |
1 |
2009 |
| Behavioral |
qualitative interview |
1 |
2016 |
| Behavioral |
qualitative interview/adherence measurements |
1 |
2016 |
| Other |
quality iq patient simulations |
1 |
2019 |
| Other |
quality of life assessment |
1 |
2018 |
| Other |
quality of life questionnaire |
1 |
2015 |
| Other |
quality of life questionnaire. |
1 |
2018 |
| Diagnostic Test |
quantitated blood volume analysis |
1 |
2019 |
| Other |
quarterly in clinic follow ups |
1 |
2010 |
| Other |
quarterly in clinic follow ups/remote monitoring |
1 |
2010 |
| Other |
quarterly remote follow ups |
1 |
2010 |
| Other |
quarterly remote follow ups / additional phone calls/remote monitoring |
1 |
2010 |
| Other |
quarterly remote follow ups/remote monitoring |
1 |
2010 |
| Other |
quarterly review arm |
1 |
2009 |
| Device |
quartet 1457q lv lead |
1 |
2015 |
| Behavioral |
question |
1 |
2018 |
| Behavioral |
question/topic prompt list |
1 |
2018 |
| Device |
quickflex micro model 1258t left heart lead |
1 |
2008 |
| Device |
quickopt |
1 |
2009 |
| Drug |
raas blockers |
1 |
2014 |
| Drug |
radioisotope |
1 |
2014 |
| Device |
rate adaptive atrial pacing using a dual-chamber pacemaker |
1 |
2014 |
| Other |
rate control |
1 |
2011 |
| Other |
rate vs rhythm control strategies for atrial fibrillation |
1 |
2008 |
| Other |
rate vs rhythm control strategies in atrial fibrillation |
1 |
2008 |
| Dietary Supplement |
re |
1 |
2014 |
| Dietary Supplement |
re/bcaa supplementation |
1 |
2014 |
| Other |
received routine treatment |
1 |
2018 |
| Behavioral |
recollection |
1 |
2011 |
| Drug |
recombinant b-type, natriuretic peptide |
1 |
2007 |
| Behavioral |
recommendation of regular moderate exercise |
1 |
2009 |
| Device |
recording doppler ultrasound signals noninvasively |
1 |
2014 |
| Other |
recording of daily activity using wristwatch accelerometers. |
1 |
2013 |
| Other |
recording of lvad data during routine visits |
1 |
2013 |
| Other |
recording of lvad data during routine visits/daily life. |
1 |
2013 |
| Other |
recoverlink technology |
1 |
2016 |
| Device |
reds-guided |
1 |
2018 |
| Behavioral |
reducing sedentary behavior |
1 |
2016 |
| Other |
reference position |
1 |
2013 |
| Other |
referral to mtm pharmacist |
1 |
2019 |
| Drug |
regadenoson |
1 |
2015 |
| Drug |
regional nerve block with a local anesthetic (lidocaine) |
1 |
2016 |
| Behavioral |
regular attention |
1 |
2018 |
| Other |
regular diet |
1 |
2016 |
| Drug |
regular management |
1 |
2017 |
| Drug |
regular management/levosimendan |
1 |
2017 |
| Behavioral |
regular, pharmacy based intervention |
1 |
2012 |
| Behavioral |
rehabilitation intervention |
1 |
2011 |
| Other |
reinforced multidisciplinary follow-up |
1 |
2019 |
| Behavioral |
relaxation response |
1 |
2011 |
| Behavioral |
relaxation technique |
1 |
2001 |
| Other |
remote ischemic conditioning (using sphygmomanometer) |
1 |
2014 |
| Other |
remote ischemic preconditioning |
1 |
2009 |
| Other |
remote monitoring |
1 |
2010 |
| Other |
remote outpatient monitoring |
1 |
2011 |
| Device |
remote patient management |
1 |
2013 |
| Device |
remote patient monitoring |
1 |
2012 |
| Device |
remote patient monitoring (motiva) |
1 |
2014 |
| Device |
remote patient monitoring (partnership for the heart) |
1 |
2007 |
| Procedure |
renal artery denervation |
1 |
2011 |
| Device |
renal denervation |
1 |
2014 |
| Device |
renal denervation with enlightn st. jude medical |
1 |
2012 |
| Device |
renal denervation with paradise recor |
1 |
2012 |
| Device |
renal denervation with symplicity flex medtronic |
1 |
2012 |
| Device |
renal denervation with symplicity flex medtronic/ardian |
1 |
2012 |
| Device |
renal denervation with v2 vessix |
1 |
2012 |
| Device |
renal sympathetic denervation |
1 |
2013 |
| Procedure |
renal sympathetic modification |
1 |
2011 |
| Device |
renewal tr2 |
1 |
2005 |
| Procedure |
replacement |
1 |
2018 |
| Other |
reports |
1 |
2009 |
| Other |
reports/notices |
1 |
2009 |
| Device |
reprieve cardiovascular system |
1 |
2019 |
| Device |
reprogramming of crt device settings to optimal electrical synchrony |
1 |
2019 |
| Behavioral |
resistance band |
1 |
2012 |
| Other |
resistance exercise training |
1 |
2015 |
| Other |
resistance physical training program |
1 |
2015 |
| Behavioral |
respecting choices first steps |
1 |
2018 |
| Other |
reveal linq icm cardiac monitor, taped on the subject’s chest rather than inserted in the body. |
1 |
2016 |
| Device |
reveal xtâ® insertable cardiac monitor |
1 |
2011 |
| Procedure |
reversible pulmonary artery banding |
1 |
2016 |
| Device |
revivent tc ventricular enhancement system |
1 |
2019 |
| Device |
rheos baroreflex activation therapy system |
1 |
2008 |
| Device |
rheosâ® system |
1 |
2009 |
| Drug |
rhnrg-1 |
1 |
2017 |
| Drug |
rhnrg-1 dose 1 |
1 |
2010 |
| Drug |
rhnrg-1 dose 2 |
1 |
2010 |
| Procedure |
rhythm control |
1 |
2011 |
| Dietary Supplement |
rice bran oil capsules |
1 |
2012 |
| Drug |
rifaximin |
1 |
2015 |
| Device |
right ventricular pacing |
1 |
2009 |
| Other |
risk stratification |
1 |
2016 |
| Other |
risk stratification/transitional care intervention |
1 |
2016 |
| Drug |
rivaroxaban, 10 mg |
1 |
2014 |
| Drug |
rivaroxaban, 7.5 mg |
1 |
2014 |
| Drug |
rlx030 (serelaxin) |
1 |
2013 |
| Drug |
rolofyline |
1 |
2008 |
| Other |
room air |
1 |
2018 |
| Other |
routine care |
1 |
2012 |
| Other |
routine in office visits |
1 |
2010 |
| Drug |
ruboxistaurin |
1 |
2016 |
| Device |
rv ddd(r)-60 |
1 |
2015 |
| Device |
rv ddd(r)-60 with av optimization |
1 |
2015 |
| Drug |
sacubitril-valsartan |
1 |
2019 |
| Drug |
sacubitril - valsartan (formerly lcz696, entrestoâ®) |
1 |
2016 |
| Drug |
sacubitril / valsartan oral tablet |
1 |
2018 |
| Drug |
sacubitril/valsartan (lcz696) matching placebo |
1 |
2015 |
| Drug |
sacubitril/valsatran |
1 |
2017 |
| Other |
saline 0.9% |
1 |
2010 |
| Other |
saline 0.9%/placebo tablet |
1 |
2010 |
| Drug |
saline infusion |
1 |
2015 |
| Drug |
saline isotonic solution |
1 |
2011 |
| Drug |
saline load |
1 |
2012 |
| placebo |
saline placebo for nitrite |
1 |
2013 |
| Drug |
saline solution for injection |
1 |
2017 |
| Dietary Supplement |
salt |
1 |
2009 |
| Dietary Supplement |
salt/fluid restriction |
1 |
2009 |
| Drug |
samsca |
1 |
2012 |
| Device |
sapien 3 thv |
1 |
2016 |
| Drug |
saxagliptin |
1 |
2016 |
| Combination Product |
sc2wear furosemide infusor |
1 |
2017 |
| Other |
screening |
1 |
2015 |
| Other |
screening for pc by means of two different screening tools |
1 |
2019 |
| Other |
screening/treatment of comorbidities |
1 |
2015 |
| Other |
script |
1 |
2013 |
| Other |
script/cpr/mechanical ventilation video. |
1 |
2013 |
| Device |
seca medical body composition analyser 515 |
1 |
2017 |
| Other |
secondary prevention |
1 |
2014 |
| Other |
secondary prevention/cardiac rehabilitation clinic |
1 |
2014 |
| Behavioral |
see simulation room, usual education |
1 |
2013 |
| Device |
seeq |
1 |
2015 |
| Device |
selective cytopheretic device |
1 |
2019 |
| Behavioral |
self-care behavior |
1 |
2019 |
| Behavioral |
self-management |
1 |
2001 |
| Behavioral |
self-management- prevention of illness |
1 |
2007 |
| Behavioral |
self-management education for heart failure |
1 |
2016 |
| Behavioral |
self-management of illness |
1 |
2007 |
| Behavioral |
self-regulation programme |
1 |
2020 |
| Behavioral |
self assessment score |
1 |
2014 |
| Behavioral |
self management education programme |
1 |
2009 |
| Drug |
seloken zok |
1 |
2002 |
| Drug |
seloken zok/toprol-xl |
1 |
2002 |
| Behavioral |
sensor-controlled digital game (scdg) |
1 |
2019 |
| Behavioral |
sensor only |
1 |
2019 |
| Device |
sequential vv pacing |
1 |
2005 |
| Genetic |
serca2a (mydicar) |
1 |
2012 |
| Drug |
serelaxin |
1 |
2013 |
| Other |
serious illness care program (sicp) |
1 |
2018 |
| Drug |
sertraline |
1 |
2004 |
| Procedure |
serum nt-probnp concentration |
1 |
2019 |
| Other |
sg1002 |
1 |
2013 |
| Other |
sham comparator |
1 |
2014 |
| Other |
sham control |
1 |
2009 |
| Other |
sham cpap treatment |
1 |
2013 |
| Device |
sham high-intensity imt |
1 |
2012 |
| Other |
sham imt |
1 |
2017 |
| Other |
sham imt / aerobic/resistance exercise |
1 |
2017 |
| Procedure |
sham room air |
1 |
2019 |
| Device |
sham tvs |
1 |
2017 |
| Diagnostic Test |
sham ultrasound evaluation of the inferior vena cava diameter |
1 |
2017 |
| Biological |
sham, no injection |
1 |
2012 |
| Drug |
shenfu zhusheye |
1 |
2014 |
| Device |
shockwave therapy |
1 |
2018 |
| Other |
short stay unit |
1 |
2017 |
| Diagnostic Test |
shuttle walk test |
1 |
2017 |
| Other |
side bar non interruptive provider checklist |
1 |
2016 |
| Behavioral |
sidera^b |
1 |
2019 |
| Other |
signs remote monitoring |
1 |
2016 |
| Drug |
sildenafil citrate |
1 |
2017 |
| Other |
simulation-based mastery learning (sbml) |
1 |
2017 |
| Other |
simultaneous determination of paco2 |
1 |
2018 |
| Other |
simultaneous determination of paco2/ptco2 |
1 |
2018 |
| Device |
simultaneous vv pacing |
1 |
2005 |
| Behavioral |
single illness management |
1 |
2006 |
| Procedure |
sinus rhythm control |
1 |
2014 |
| Drug |
sitagliptin 100mg |
1 |
2018 |
| Drug |
sitaxsentan sodium |
1 |
2006 |
| Other |
sitting position |
1 |
2013 |
| Procedure |
six minute walk test |
1 |
2014 |
| Drug |
sk&f-105517-d 10 mg capsule |
1 |
2008 |
| Drug |
sk&f-105517-d 20 mg capsule |
1 |
2008 |
| Drug |
sk&f-105517-d 40 mg capsule |
1 |
2008 |
| Behavioral |
sleep education |
1 |
2013 |
| Behavioral |
sleep monitoring |
1 |
2018 |
| Behavioral |
slow breathing |
1 |
2009 |
| Drug |
slv320 |
1 |
2005 |
| Behavioral |
social incentive |
1 |
2017 |
| Behavioral |
social network feedback |
1 |
2018 |
| Behavioral |
sodium-restricted diet (srd) |
1 |
2009 |
| Drug |
sodium bicarbonate |
1 |
2007 |
| Drug |
sodium ferric gluconate |
1 |
2013 |
| Drug |
sodium nitrite inhalation solution |
1 |
2014 |
| Behavioral |
sodium reduction |
1 |
2012 |
| Other |
sodium restricted diet |
1 |
2016 |
| Other |
sodium restriction |
1 |
2013 |
| Drug |
sofosbuvir |
1 |
2016 |
| Drug |
sofosbuvir/ledipasvir fixed dose combination(sof/ldv fdc) |
1 |
2016 |
| Device |
software beutel tm |
1 |
2008 |
| Drug |
soluble epoxide hydrolase |
1 |
2008 |
| Drug |
somatropin |
1 |
2020 |
| Device |
somnotouch device (somnomedics) |
1 |
2015 |
| Drug |
sonazoid |
1 |
2017 |
| Other |
sonr |
1 |
2011 |
| Device |
sonr automatic optimization feature turned on ("av |
1 |
2015 |
| Device |
sonr automatic optimization feature turned on (“av/vv”). |
1 |
2015 |
| Device |
sonr crt optimization ‘off’ |
1 |
2013 |
| Device |
sonr crt optimization ‘on’ |
1 |
2013 |
| Drug |
sotagliflozin (sar439954) |
1 |
2018 |
| Behavioral |
specialized community disease management |
1 |
2014 |
| Device |
sphygmocor |
1 |
2007 |
| Device |
spinal cord stimulation system |
1 |
2011 |
| Drug |
spironolacton |
1 |
2015 |
| Drug |
sr121463b |
1 |
2006 |
| Other |
srd |
1 |
2014 |
| Behavioral |
srd adoption |
1 |
2017 |
| Behavioral |
srd intervention vs. control diet on hfpef functional cardiovascular risk factors |
1 |
2017 |
| Other |
st2-guided strategy |
1 |
2016 |
| Other |
standard |
1 |
2008 |
| Procedure |
standard-of-care treatment with mock mapping |
1 |
2008 |
| Procedure |
standard-of-care treatment with mock mapping/injection procedures. |
1 |
2008 |
| Other |
standard cardiac imaging |
1 |
2010 |
| Device |
standard configuration vs. azygos coil |
1 |
2008 |
| Other |
standard default ad forms |
1 |
2013 |
| Behavioral |
standard dietary sodium education |
1 |
2016 |
| Biological |
standard dose quadrivalent influenza vaccine |
1 |
2016 |
| Other |
standard management |
1 |
2013 |
| Other |
standard of care arm |
1 |
2018 |
| Other |
standard of care as vasoactive agent |
1 |
2020 |
| Drug |
standard of care diuretic therapy |
1 |
2016 |
| Other |
standard of care for heart failure/coronary artery disease |
1 |
2013 |
| Drug |
standard of care iv antihypertensive |
1 |
2008 |
| Other |
standard of care medical managment therapy for heart failure |
1 |
2012 |
| Other |
standard outpatient heart failure management |
1 |
2017 |
| Procedure |
standard primary health care |
1 |
2012 |
| Drug |
standard therapy for heart failure |
1 |
2011 |
| Drug |
standard treatment strategy |
1 |
2013 |
| Other |
standard v-v timing settings |
1 |
2014 |
| Behavioral |
standardized education sessions |
1 |
2013 |
| Other |
standardized heart failure discharge summary to primary care physiciansâ© |
1 |
2013 |
| Drug |
starting dpp-4 inhibitor after treatment of heart failure |
1 |
2014 |
| Other |
static handgrip |
1 |
2015 |
| Drug |
statin |
1 |
2010 |
| Drug |
statin therapy |
1 |
2012 |
| Biological |
stem cells administered to participants |
1 |
2017 |
| Drug |
stem cells infusion |
1 |
2016 |
| Procedure |
stents |
1 |
2000 |
| Behavioral |
stepped care for depression |
1 |
2016 |
| Drug |
stepped pharmacologic care |
1 |
2008 |
| Device |
stimulation of the diaphragm |
1 |
2008 |
| Device |
stimulette r4x |
1 |
2016 |
| Drug |
strata 1 cxl-1020 |
1 |
2010 |
| Drug |
strata 2 cxl-1020 |
1 |
2010 |
| Drug |
strata 3 cxl-1020 |
1 |
2010 |
| Other |
strength |
1 |
2019 |
| Behavioral |
strength exercise intervention |
1 |
2018 |
| Behavioral |
strength training intervention |
1 |
2005 |
| Other |
strength/balance training/nutrition education |
1 |
2019 |
| Diagnostic Test |
stress cmr |
1 |
2017 |
| Diagnostic Test |
stress echocardiography |
1 |
2017 |
| Other |
stretching exercises |
1 |
2016 |
| Behavioral |
stretching/flexibility |
1 |
2014 |
| Other |
stretching/resistance training |
1 |
2008 |
| Behavioral |
structured access to a wii game computer (wii) |
1 |
2013 |
| Other |
structured telephone |
1 |
2011 |
| Other |
structured telephone / remote outpatient monitoring |
1 |
2011 |
| Other |
structured transitional protocol planning post-discharge care |
1 |
2020 |
| Other |
subcutaneous ultrasound |
1 |
2015 |
| Other |
subjects with chf via conventional clinic visit according to the latest relevant guidelines |
1 |
2013 |
| Diagnostic Test |
submã¡ximal functional capacity assesment by 6 minutes walk test |
1 |
2019 |
| Other |
submaximal exercise test |
1 |
2015 |
| Drug |
substance p |
1 |
2012 |
| Drug |
sucrose (3%) |
1 |
2008 |
| Drug |
sucrosomial iron |
1 |
2019 |
| Drug |
sugammadex |
1 |
2012 |
| Diagnostic Test |
supersonic image |
1 |
2019 |
| Behavioral |
supervised exercise training program |
1 |
2002 |
| Behavioral |
supervised hospital-based exercise training |
1 |
2011 |
| Other |
supportive care management programme |
1 |
2020 |
| Procedure |
surgical intervention |
1 |
2016 |
| Procedure |
surgical placement of jarvik 2015 vad |
1 |
2016 |
| Device |
surgical placement of the jarvik 2015 vad |
1 |
2016 |
| Procedure |
surgical resection of the greater splanchnic nerve |
1 |
2018 |
| Drug |
suspending dpp-4 inhibitor after treatment of heart failure |
1 |
2014 |
| Drug |
suspending dpp-4 inhibitor, in outpatient service |
1 |
2014 |
| Procedure |
svr |
1 |
2001 |
| Other |
swift home intervention |
1 |
2014 |
| Procedure |
symptom management service for heart failure |
1 |
2011 |
| Behavioral |
symptom questionnaire |
1 |
2015 |
| Behavioral |
symptom reporting |
1 |
2011 |
| Drug |
symptom treatment |
1 |
2016 |
| Other |
symptoms |
1 |
2016 |
| Other |
symptoms/signs remote monitoring |
1 |
2016 |
| Device |
syncardia 50cc temporary total artificial heart (tah-t) |
1 |
2014 |
| Device |
syncav programmed on |
1 |
2019 |
| Behavioral |
systemchange |
1 |
2017 |
| Drug |
tadalafil |
1 |
2012 |
| Behavioral |
tai chi |
1 |
2012 |
| Behavioral |
tai chi training |
1 |
2011 |
| Procedure |
tailored healthmedia programs on ehr patient portal |
1 |
2005 |
| Behavioral |
teach back method of patient discharge teaching |
1 |
2011 |
| Behavioral |
teach to goal (ttg) |
1 |
2006 |
| Device |
tele-health monitoring |
1 |
2010 |
| Device |
tele-monitoring/health coaching |
1 |
2015 |
| Device |
telecardiology program |
1 |
2014 |
| Behavioral |
telehealth monitoring |
1 |
2006 |
| Device |
telehealth self management (tsm) |
1 |
2014 |
| Device |
telehomecare |
1 |
2005 |
| Device |
telemonitoring assisted self-care |
1 |
2012 |
| Device |
telemonitoring devices |
1 |
2019 |
| Procedure |
telemonitoring for patients with congestive heart failure |
1 |
2012 |
| Device |
telemonitoring in patients with heart failure |
1 |
2007 |
| Device |
telemonitoring of weight, pulse |
1 |
2015 |
| Device |
telemonitoring of weight, pulse/blood pressure |
1 |
2015 |
| Other |
telephone-delivered api |
1 |
2011 |
| Behavioral |
telephone-delivered bei |
1 |
2011 |
| Behavioral |
telephone-delivered bi |
1 |
2011 |
| Other |
telephone call |
1 |
2018 |
| Behavioral |
telephone follow-up |
1 |
2015 |
| Other |
telephone management |
1 |
2007 |
| Other |
telephone management with standard patient education |
1 |
2007 |
| Other |
telephone management/a motivational intervention |
1 |
2007 |
| Behavioral |
telephone monitoring |
1 |
2019 |
| Procedure |
telephone, videophone care |
1 |
2003 |
| Other |
telephonic disease management |
1 |
2014 |
| Behavioral |
telerehabilitation for patients with a cardiac resynchronisation device |
1 |
2020 |
| Drug |
telmisartan |
1 |
2007 |
| Drug |
telmisartan, bisoprolol |
1 |
2007 |
| Procedure |
temporary pacing study |
1 |
2020 |
| Drug |
terbutaline |
1 |
2005 |
| Drug |
terbutaline infusion |
1 |
2008 |
| Drug |
terbutaline/metoprolol/carvedilol |
1 |
2005 |
| Behavioral |
test of general knowledge |
1 |
2015 |
| Device |
testing of the autocapture features of the device |
1 |
2008 |
| Drug |
testosterone replacement |
1 |
2013 |
| Dietary Supplement |
tetrahydrobiopterin (bh4) |
1 |
2017 |
| Behavioral |
text message reminders |
1 |
2017 |
| Procedure |
the cytokines modulations |
1 |
2016 |
| Device |
the gpsâ„¢ ii platelet concentrate separation kit |
1 |
2007 |
| Device |
the jarvik 2000 ventricular assist system |
1 |
2007 |
| Procedure |
the kansas city cardiomyopathy questionnaire (kccq) |
1 |
2006 |
| Procedure |
therapeutic thoracentesis |
1 |
2008 |
| Radiation |
thoracic ct |
1 |
2020 |
| Procedure |
thoracotomy |
1 |
2014 |
| Device |
thoratec heartmate ii left ventricular assist system (lvas) |
1 |
2005 |
| Device |
threshold imt |
1 |
2019 |
| Device |
threshold inspiratory muscle trainer |
1 |
2018 |
| Device |
thresholdâ® imt hs730, respironics inc, cedar grove, nj, usa |
1 |
2015 |
| Behavioral |
time management |
1 |
2017 |
| Procedure |
titration after the randomization phase |
1 |
2011 |
| Procedure |
titration during the randomization phase |
1 |
2011 |
| Device |
titration of nocturnal oxygen needs to prevent desaturations |
1 |
2017 |
| Dietary Supplement |
to surgery patients, tocopherol capsules. |
1 |
2008 |
| Dietary Supplement |
to surgery patients, tocotrienol capsules. |
1 |
2008 |
| Dietary Supplement |
tocotrienol to healthy subjects. |
1 |
2008 |
| Drug |
tolvaptan 30 mg |
1 |
2016 |
| Drug |
tolvaptan 30 mg / iv diuretics |
1 |
2016 |
| Drug |
tolvaptan tab 15 mg |
1 |
2018 |
| Drug |
tolvaptan tablet 15mg |
1 |
2017 |
| Drug |
tolvaptan/samsca |
1 |
2012 |
| Drug |
tolvaptan/torasemide |
1 |
2015 |
| Behavioral |
tomas |
1 |
2018 |
| Other |
tomography positron emission |
1 |
2015 |
| Drug |
tonapofylline |
1 |
2008 |
| Procedure |
toning |
1 |
2005 |
| Behavioral |
topic prompt list |
1 |
2018 |
| Drug |
toprol-xl |
1 |
2002 |
| Drug |
torasemide |
1 |
2015 |
| Drug |
torasemide prolonged release |
1 |
2006 |
| Device |
traditional biventricular pacing |
1 |
2013 |
| Drug |
traditional chinese medicine |
1 |
2013 |
| Other |
traditional icd programming |
1 |
2013 |
| Device |
tragus stimulation |
1 |
2016 |
| Other |
training |
1 |
2013 |
| Other |
training of general practitioners in an uptitration protocol. |
1 |
2010 |
| Behavioral |
training program intervention |
1 |
2008 |
| Drug |
trandolapril |
1 |
2006 |
| Diagnostic Test |
trans-thoracic echocardiography |
1 |
2018 |
| Procedure |
trans-ventricular-septal placement of lv pacing lead |
1 |
2013 |
| Device |
transcatheter atrial shunt system |
1 |
2018 |
| Device |
transcatheter mitral valve repair |
1 |
2018 |
| Device |
transcutaneous electrical stimulation |
1 |
2018 |
| Other |
transesophageal echocardiography (tee) |
1 |
2017 |
| Other |
transitional care intervention |
1 |
2016 |
| Behavioral |
transitional care model |
1 |
2014 |
| Procedure |
transmitral flow estimation |
1 |
2016 |
| Combination Product |
transplant with hcv positive donor, followed by surveillance |
1 |
2017 |
| Combination Product |
transplant with hcv positive donor, followed by surveillance/treatment of viremia |
1 |
2017 |
| Procedure |
transthoracic echocardiogram (tte) assesment |
1 |
2016 |
| Diagnostic Test |
transthoracic ecocardiogram |
1 |
2019 |
| Device |
transthoracic impedance |
1 |
2007 |
| Device |
transvenous left ventricular lead placement |
1 |
2007 |
| Procedure |
transvenous placement of left ventricular lead |
1 |
2011 |
| Drug |
treatment a |
1 |
2019 |
| Other |
treatment as per model probability |
1 |
2010 |
| Other |
treatment as per usual care |
1 |
2010 |
| Behavioral |
treatment as usual |
1 |
2014 |
| Drug |
treatment b |
1 |
2019 |
| Drug |
treatment c |
1 |
2019 |
| Drug |
treatment d |
1 |
2019 |
| Biological |
treatment group |
1 |
2007 |
| Other |
treatment in day-care heart failure unit |
1 |
2017 |
| Other |
treatment of comorbidities |
1 |
2015 |
| Other |
treatment of elderly patients in a gmw |
1 |
2008 |
| Other |
treatment of elderly patients in ghhs |
1 |
2008 |
| Combination Product |
treatment of viremia |
1 |
2017 |
| Drug |
treatment with either metoprolol |
1 |
2007 |
| Drug |
treatment with either metoprolol/carvedilol |
1 |
2007 |
| Device |
triage bnp test |
1 |
2005 |
| Procedure |
tricuspid valve repair |
1 |
2018 |
| Procedure |
tricuspid valve repair (tvr) |
1 |
2015 |
| Procedure |
tricuspid valve repair/replacement |
1 |
2018 |
| Device |
triple-site biventricular pacing with peri-operative echo guidance |
1 |
2015 |
| Device |
triple-site cardiac resynchronization |
1 |
2008 |
| Drug |
trv027 dose #1 |
1 |
2013 |
| Drug |
trv027 dose #2 |
1 |
2013 |
| Drug |
trv027 dose #3 |
1 |
2013 |
| Drug |
tt-00920 |
1 |
2020 |
| Device |
tunneled pleural catheter |
1 |
2018 |
| Drug |
two-hour dwell with 10% dextrose in sterile water |
1 |
2018 |
| Drug |
two-hour dwell with dianeal low-calcium with 4.25% dextrose |
1 |
2018 |
| Behavioral |
ufa dietary recommendations |
1 |
2019 |
| Drug |
ularitide |
1 |
2012 |
| Other |
ultra conservative icd programming |
1 |
2013 |
| Other |
ultrafiltration using bvm |
1 |
2009 |
| Diagnostic Test |
ultrasound evaluation of the inferior vena cava diameter |
1 |
2017 |
| Diagnostic Test |
ultrasound examination |
1 |
2018 |
| Procedure |
ultrasound examination by nurses |
1 |
2013 |
| Procedure |
undersizing mitral annuloplasty |
1 |
2017 |
| Other |
unfiltered diesel exhaust |
1 |
2013 |
| Other |
untraining |
1 |
2020 |
| Drug |
upfront therapy with oral spironolactone |
1 |
2013 |
| Procedure |
upgrade to triple ventricular site crt |
1 |
2009 |
| Other |
upper extremity aerobic exercise |
1 |
2018 |
| Other |
upstream therapy |
1 |
2009 |
| Other |
urine sample |
1 |
2012 |
| Drug |
urocortin 2 |
1 |
2011 |
| Drug |
urocortin 2, urocortin 3 |
1 |
2012 |
| Drug |
urocortin 2, urocortin 3/substance p |
1 |
2012 |
| Drug |
urocortin 3 |
1 |
2011 |
| Drug |
urotensine ii |
1 |
2008 |
| Behavioral |
use of mobilemedminder |
1 |
2012 |
| Device |
use of the c3-cloud it system |
1 |
2019 |
| Drug |
usual care (standard-of-care) arm |
1 |
2019 |
| Device |
usual care group |
1 |
2007 |
| Other |
usual care iv diuretics |
1 |
2017 |
| Procedure |
usual care of acute pulmonary oedema |
1 |
2007 |
| Behavioral |
usual care program |
1 |
2019 |
| Behavioral |
usual care treatment |
1 |
2009 |
| Behavioral |
usual care with attention control |
1 |
2016 |
| Behavioral |
usual care with educational material |
1 |
2005 |
| Behavioral |
usual care/optimal discharge planning |
1 |
2018 |
| Behavioral |
usual hf care |
1 |
2015 |
| Drug |
usual long term cardiac medications |
1 |
2005 |
| Other |
usual lvad care |
1 |
2017 |
| Drug |
usual medications |
1 |
2017 |
| Other |
usual outpatient care |
1 |
2019 |
| Other |
usual treatment of patients with developing acute heart failure |
1 |
2012 |
| Device |
v-lapâ„¢ system |
1 |
2018 |
| Device |
v-wave interatrial shunt |
1 |
2018 |
| Device |
vagus nerve stimulation (vns) |
1 |
2013 |
| Other |
valsalva maneuver |
1 |
2013 |
| placebo |
valsartan (lcz696) matching placebo |
1 |
2015 |
| Drug |
valsartan 160 mg |
1 |
2006 |
| Drug |
valsartan 160 mg bid |
1 |
2006 |
| Drug |
valsartan oral tablet |
1 |
2018 |
| placebo |
valsartan placebo |
1 |
2016 |
| Drug |
valsartan/placebo |
1 |
2017 |
| Drug |
valsartan/sacubitril/placebo |
1 |
2017 |
| Drug |
valsatran |
1 |
2017 |
| Other |
values inventory (vi) |
1 |
2005 |
| Drug |
vasodilator |
1 |
2017 |
| Drug |
vasopressin v2 receptor antagonist |
1 |
2002 |
| Biological |
vaxigrip) |
1 |
2009 |
| Other |
vehicle control |
1 |
2009 |
| Procedure |
venous plethysmography |
1 |
2014 |
| Other |
ventilation therapy |
1 |
2010 |
| Device |
ventrassist left ventricular assist device |
1 |
2007 |
| Device |
ventricular assist device system |
1 |
2019 |
| Device |
ventricular) implantable defibrillator |
1 |
2006 |
| Other |
verbal information |
1 |
2016 |
| Other |
verbal information/discussion |
1 |
2016 |
| Drug |
vericiguat |
1 |
2016 |
| Drug |
vericiguat (bay1021189) 2.5 mg, 5 mg |
1 |
2018 |
| Drug |
vericiguat (bay1021189) 2.5 mg, 5 mg/10 mg ir tablets |
1 |
2018 |
| Drug |
verinurad |
1 |
2020 |
| Device |
vfi |
1 |
2019 |
| Behavioral |
viccy |
1 |
2019 |
| Drug |
vildagliptin |
1 |
2009 |
| Behavioral |
vipassana meditation practice |
1 |
2008 |
| Behavioral |
vipassana meditation practice/instruction |
1 |
2008 |
| Device |
visone ads |
1 |
2018 |
| Device |
vitalpatch biosensor |
1 |
2018 |
| Dietary Supplement |
vitamin b1 |
1 |
2009 |
| Drug |
vitamin c |
1 |
2007 |
| Dietary Supplement |
vitamin c 1000 mg |
1 |
2019 |
| Dietary Supplement |
vitamin c 500 mg |
1 |
2019 |
| Drug |
vitamin d alone |
1 |
2014 |
| Drug |
vitamin d/fish oil |
1 |
2014 |
| Drug |
vitamin d3 (cholecalciferol) |
1 |
2012 |
| Device |
vitaria system |
1 |
2018 |
| Device |
vitatron biventricular pacemaker |
1 |
2005 |
| Device |
vpd implant system |
1 |
2007 |
| Device |
vr 9250 |
1 |
2010 |
| Device |
vr 9250 / dr 9550 / crt 9750 |
1 |
2010 |
| Device |
vv"). |
1 |
2015 |
| Other |
wait list |
1 |
2008 |
| Behavioral |
walking exercise |
1 |
2005 |
| Other |
walking/light weights |
1 |
2014 |
| Drug |
warfarin / lmwh |
1 |
2018 |
| Drug |
warfarin titrated to an inr of 2.5-3.0 |
1 |
2000 |
| Behavioral |
web-based training |
1 |
2019 |
| Behavioral |
web-based training/telephone monitoring |
1 |
2019 |
| Other |
web based telemonitoring system |
1 |
2020 |
| Other |
website |
1 |
2012 |
| Other |
website/interactive platform with telemonitoring. |
1 |
2012 |
| Procedure |
weigh subjects on a scale in the standing position |
1 |
2010 |
| Behavioral |
williams lifeskills |
1 |
2017 |
| Device |
wise-crt |
1 |
2018 |
| Device |
wise system |
1 |
2016 |
| Other |
withdrawal of aspirin |
1 |
2012 |
| Drug |
withdrawal of digoxin |
1 |
2011 |
| Other |
withdrawal of oral medication (phosphodiesterase-5 inhibitor) in pretreated patients |
1 |
2019 |
| Drug |
withdrawal of statin therapy |
1 |
2012 |
| Other |
without autoset cs2 |
1 |
2007 |
| Other |
without codeine |
1 |
2020 |
| Device |
without defibrillator |
1 |
2005 |
| Device |
without implanted cardioverter defibrillator |
1 |
2017 |
| Radiation |
x-rays in hospital |
1 |
2010 |
| Other |
yã´ga |
1 |
2017 |
| Behavioral |
yoga classes |
1 |
2008 |
| Behavioral |
yoga program at home using internet technology |
1 |
2014 |
| Drug |
zepatier |
1 |
2017 |
| Drug |
zinc acetate |
1 |
2008 |
| Drug |
zolpidem tartrate |
1 |
2017 |